Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
1973-04-01

The determination of thiamin and its derivatives in brain tissue of
control, thiamin-deficient, oxythiamin- and pyrithiamin-treated rats
David S. Murdock
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Chemistry Commons

BYU ScholarsArchive Citation
Murdock, David S., "The determination of thiamin and its derivatives in brain tissue of control, thiamindeficient, oxythiamin- and pyrithiamin-treated rats" (1973). Theses and Dissertations. 8311.
https://scholarsarchive.byu.edu/etd/8311

This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more
information, please contact ellen_amatangelo@byu.edu.

THE DETERMINATION OF THIAMIN AND ITS DERIVATIVES
IN BRAIN TISSUE OF CONTROL, THIAMIN -DEFICIENT,
OXYTHIAMIN- AND PYRITHIAMIN-TREATED RATS

A Dissertation
Presented to the
Department of Chemistry
Brigham Young University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy

by
David S. Murdock
April 1973

This dissertation, by David S. Murdock, is accepted in its
present form by the Department of Chemistry of Brigham Young
University as satisfying the dissertation requirement for the degree
Doctor of Philosophy.

Typed by: Donna E. Hague

ii

ACKNOWLEDGMENTS
This research has been supported by funds received from
the National Institute of Health grant number AM-01448-14.
Sincere appreciation is extended to Dr. Clark J. Gubler for
his continuous patience and insight which have made this academic
venture possible.
The helpful discussions and suggestions of my cnlleagues,
James Sutherland, John Susa, James Peterson, Dong Park, and Dee
Rees, are gratefully acknowledged.
The hydroxyethylthiamin, that was received as a gift from
Dr. Morita of Japan, is also gratefully acknowledged.
This author is appreciative nf the encouragement and support
my family has extended to me during my graduate research period.

iii

TABLE OF CONTENTS
ACKNOWLEDGMENTS

111

LIST OF TABLES .

vi

LIST OF FIGURES

I

•

e

e

•

•

e

e

•

•

e

I

•

•

•

•

e

•

viii

STRUCTURES

X

INTRODUCTION

1

11

LITERATURE REVIEW
Thiamin, HET, 0TH and PTH Assays
Thiamin Administration
Thiamin Distribution in Animals
Effect of Thiamin Deficiency in Experimental Animals
The Effects of 0TH and PTH on the Rat
Effect of Thiamin Deficiency and Thiamin Antagonist
Treatment on Adenosine Triphosphate Levels
Discovery and Identification of HET

46

MATERIALS AND EQUIPMENT
Materials
Equipment

50

METHODS
Diet and Injection Schedule
Sacrifice Schedule
Extraction and Neutralization of Homogenate
Isolation of TDP and TTP
Dephosphorylation
Decalso Purification
Preparation of Total Thiamin, HET, and PTH Samples
Preparation of Free Thiamin Samples
Calculation of Thiamin, HET, and PTH Levels
Fluorescent Assay
iv

Thiamin Assay
HET Assay
PTH Assay

58

RESULTS
Weight Gain of Rats
Thiamin and HET Assays
Total Thiamin Levels in Control, Thiamin-deficient,
OTH- and PTH-treated Rats
TDP + TTP, TMP, and Free Thiamin Levels
HET and PTH Levels

94

DISCUSSION
SUMMARY

.

BIBLIOGRAPHY

105

V

LIST OF TABLES
Table

Page
Per cent Decrease of q<;, -Keto Acid Dehydrogenase
Activity in vitro of Terminal Thiamin-deficient,
OTH- and PTH-treated Rats . . . " .. . . • • •

27

2.

Thiamin-deficient Diet .

47

3.

Elution of Thiamin from Decalso Column

62

4.

Elution of Thiamin Plus HET frnm Decalso Column

63

s.

Recovery of Thiamin and HET from Deproteinated
Brain Homogenate after Incubation at 48°c
for Three Hours . • . • . • . • • . . . . • .

1.

.

65

6.

Elution of HET from Decalso Column

66

7.

Average Pt)r cent E-·ror Encountered in the Thiamin,
HET, and PTH Assay . . . . . . • . . . • . . .

67

8.

Thiamin and HET Assay Studies

68

9.

Interference of PTH in the Thiamin Assay

69

10.

Thiamin Levels in Fresh and Frozen Brain Tissue
Homogenates . . . . • • •

71

11.

Interference of PTH in the HET Assay

73

12.

Elution of PTH from Decalso Column

77

13.

Interference of Thiamin and HET in the PTH Assay

80

14.

Brain Levels of Total Thiamin, Free Thiamin, TMP
and TDP + TTP in Control, Thiamin-deficient,
OTH- and PTH-treated Rats and PTH Levels in
PTH-treated Rats - -1970 Analysis

82

vi

Table

15.

Page
Brain Levels of Total Thiamin, TDP + TTP and
HET in Control, Thiamin -deficient, OTHand PTH-treated Rats and PTH Levels in
PTH-treated Rats - -1971 Analysis

vii

84

LIST OF FIGURES
Figure

Page

1.

Minimum Levels of Thiamin Required to Maintain the Growth Rate of Rats . . . • . . .

15

2.

Thiamin Distribution in an Animal

16

3.

Mechanism of Thiamin Catalysis in the Formation
of Benzoin . . . . . . . . . . . .

38

Competitive Reaction between Thiamin, Acetaldehyde
and Benzaldehyde . . . • . . . . • • . . . . . .

40

5.

Average Weight Gain of Control, Thiamin-deficient,
OTH- and PTH-treated Rats --1970 Analysis .

59

6.

Average Weight Gain of Control, Thiamin-deficient,
OTH- and PTH-treated Rats- -1971 Analysis . . • .

60

7.

Fluorometric Scan of Thiochrome Formed in the
Thiamin Assay . • . .
• . . • • . .

70

8.

Rate of Breakdown of HET

72

9.

Fluorometric Scan of Thiochrome Formed in the
HET As say
• . . . . . • . . . . . •

75

Chromatographic Separation of Thiamin and HET

76

Fluor om etric Scan of Pyrichrome Formed in the
PTH Assay
• • . . . . . . . . . •

79

12.

Brain Levels of Total Thiamin in Control, Thiamindeficient, OTH- and PTH-treated Rats . • . . • .

86

13.

Brain Levels of TDP + TTP in Control, Thiamindeficient, OTH- and PTH-treated Rats

88

Brain Free Thiamin Levels in Control, Thiamindeficient, OTH- and PTH-treated Rats

90

4.

11.

14.

viii

Figure

Page

15.

Brain HET Levels in Control, Thiamin-deficient,
OTH- and PTH-treated Rats . . . •

92

16.

Brain PTH Levels in PTH-treated Rats

93

ix

STRUCTURES
Thiamin chloride
3-[( 4!...amino-2'-methy-1-5'-pyrimidinyl)methyl] -2-( hydroxyethyl)-4methylthiazolium chloride

CH3

NH
N

3

2'
~

R=H

= TMP· Cl

Thiamin chloride monophosphate

0

II

R=OP-OH
I
OH
= TDP· Cl

Thiamin chloride diphosphate

0
I

0
I

R=OPO-P-OH
I
I
OH OH
Thiamin chloride triphosphate

= TTP· Cl
0
I

0

II

0
I

R=OPO-P-OP-OH
OH OH OH
2( o<: -hydroxyethyl)-thiamin chloride

X

Oxythiamin
3- [(4 -hydroxy-2'-methyl-5'pyrimidinyl)-methyl J 2 -(hydroxyethyl)-4-methylthiazolium chloride
1

= OTH· Cl

Pyrithiamin bromide
1- [ (4-amino-2-methyl-5-pyrimidinyl) = PTH· Br
-methyl] -3-(2-hydroxyethyl)-2-methylpyridinium bromide)

Thiochrome
2, 7-dimethylthiachromine -8-ethanol

Pyrichrome

Xl

INTRODUCTION
Beriberi, a human thiamin deficiency disease, is associated
mainly with populations such as in the Far East and South Asian
countries that depend on over-milled rice for daily nourishment.

Beri-

beri was shown to be due to nutritional factors by R. R. Williams and
E. B. Vedder.

In 1910, they prepared the earliest crude concentrated

thiamin extract from rice bran which they used for treatment of beriberi
in the Philippines [ Williams ( 19 61)].
A year after thiamin was synthesized by R. R. Williams, the
diphosphate ester of the vitamin was identified as the cofactor for
brewer's yeast pyruvate decarboxylase [ Lohman and Schuster (1937)].
Lipmann (1939) and Silverman and Workman (1941) identified thiamin
diphosphate (TDP) as a cofactor to bacterial pyruvate oxidative
enzyme preparations.

Gavrile scu and Peters ( 1931) reported that the

brain slices of thiamin-deficient pigeons showed a loss of Oz consumption.

An intercerebral injection of thiamin extracts from yeast caused

an increase to normal Oz uptake.

This injection of thiamin cured the

condition of opisthotonus in the birds.

Ochoa and Peters (1938), using

an autoclaved yeast preparation free of TDP with pure TDP as the
standard, enzymatically determined the TDP content of normal and
thiamin-deficient pigeon tissues and found that the levels of TDP in
l
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the deficient tissues were less than one-third of normal.

Injection of

thiamin concentrates corrected the avitaminotic symptoms and increased
the tis sue thiamin to normal levels.
Peters (1938) demonstrated that the rate of oxygen uptake by
pigeon brain slices was directly proportional to the concentration of
thiamin in the incubation media.

He also showed that pyruvate util-

ization by the slices was increased by addition of thiamin.
et al. (1942) isolated the pyruvate and

o(

Green

-ketoglutarate decarboxy-

lation complexes from pig heart and found that TDP was a cofactor for
these systems.

The amount of pyruvate which was used up equalled

the amount of acetoin and COz formed in their system.

The ti:. -keto-

glutarate was oxidized quantitatively to equal amounts of succinic
semialdehyde and COz.
Gunsalus (1955) and Reed (1960) found that TDP was a cofactor
for pyruvate dehydrogenase, one of the three enzymes of the pyruvate
oxidase complex in mammalian tissues.

Pyruvate is oxidized to

acetylcoenzyme A (AcCoA) by this complex.

The AcCoA is then

utilized by the citric acid cycle, the main energy cycle of aerobic
animal cells.

The pyruvate dehydrogenase enzyme is therefore a key

enzyme for the complete utilization of carbohydrate as a source of
energy for the cell.

Barron et al. ( 1941) and Debusk ( 1952) re -

ported that TDP was a necessary cofactor for the oxidation of
cC -ketoglutarate to succinyl CoA in the citric acid cycle.

The

3

requirement of TDP for the activity of transketolase was reported by
Racker

~

al. ( 1953 ).

The transketolase enzyme is the rate -limiting

enzyme of the pentose phosphate shunt, which is found in the cytoplasmic portion of the cell.
The distribution of the various forms of thiamin in brain,
heart, liver, and kidney of normal rats is similar.

About 5% of the

total thiamin in these tissues exists as free thiamin, 10% as thiamin
monophosphate (TMP), 80% as the diphosphate and 5% as thiamin triphosphate (TTP) [Rindi and Guiseppe ( 1961)].

Other investigators

have shown that a thiamin-deficient condition is associated with a
decrease in the oC-keto acid dehydrogenase activity in rat tissues
[Gubler (1961), Gubler and Bethsold (1962), Bennett et al.

(1966,

1969), McCandless and Schenker (1968), and Reinauer et al. (1968)].
Although only the diphosphate ester of thiamin presently is recognized
to act as a coenzyme in mammalian systems, evidence is accumulating
which indicates that TDP and/or TTP may play a necessary role in
neuronal function [see Cooper and Pincus ( 1967) for review J.
Tanaka and Cooper (1968) identified thiamin by a fluorescent
technique in nerve tissue.

Cooper (1968) reported that pyrithiamin

(PTH), a thiamin antagonist, when added to rabbit vagus nerve homogenates, does not affect the oC -keto acid dehydrogenase or transketolase activity in these tissues.

Cooper also found that PTH displaces

thiamin from the rabbit vagus nerve preparations and that thiamin was
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localized mainly in the membrane structure of these tissues rather than
in the axoplasm.

Itokawa and Cooper (1969) found that neuroactive

drugs such as acetylcholine, tetrodotoxin, ouabain, and K+ displaced
thiamin from frog spinal cord preparations.

Thiamin diphosphatase

was localized in the membrane portion of the nerves.

Also, Itokawa

and Cooper ( 1970) discovered that a significant percentage of thiamin
was released from isolated rat nerve mitochondrial and microsomal
fractions by acetylcholine, tetrodotoxin, snake venom and thiamin
antagonists oxythiamin (0TH) and PTH.
"The experimental evidence in support of a role of thiamin
in nerve conduction which is independent of its function as a coenzyme
is strongly suggestive but far from equivocal." [Cooper and Pincus
(1967)

J
Recently, a specific thiamin triphosphatase has been isolated

from rat brain.

This enzyme is distinct from nucleotide triphosphat-

ases already characterized [Barchi and Brown ( 1971)].

It has also

been reported that a neurological condition that is due to a genetic
defect is characterized by lack of TTP in the patient's brain.

This

neurological condition is similar to Wernick's encephalopathy, a
severe form of beriberi.

An inhibitor can be extracted from the brain

tissue, blood, urine, and spinal fluid of these patients which prevents
the formation of TTP in rat brain by TDP-adenosine triphosphate
phosphotransferase enzyme preparation [ Cooper ~ al. ( 1969)].
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The most popular thiamin antagonists which have been used
to study the condition of thiamin insufficiency are 0TH and PTH
because they produce different symptoms in the rat.

In the terminal

stages of treatment, the OTH-treated rat never develops convulsions
[Gurtner (1961), Gubler (1961)], while the PTH rat almost always
develops a polyneuritic condition [Cerecedo and Eich ( 1954), Gurtner
(1961), Gubler (1961)].

Sometimes the terminal thiamin-deficient-

treated rat experiences convulsions [Robertson~ al. 1968)].

It is

felt by some that the central nervous system is affected by thiamin
deficiency and PTH treatment, although the particular biochemical
impairment has not been clearly identified [McCandless and Schenker
(1968), Dreyfus (1958), Robertson et al. (1968), Collins (1967), Rindi
and Sciorelli ( 1970)

J.

The level and distribution of thiamin derivatives in the OTHtreated rat is probably normal since only a very small amount of 0TH
is able to cross the blood-brain barrier [Rindi ~ al. (1963)].

Also

Gubler (1961) and Bennett et al. (1969) report that the cl:. -keto acid
dehydrogenase activity is normal in brain tissue of OTB-treated rats.
PTH, however, accumulates in rat brain tissue as well as in other
tissues [Morita~ al. ( 1968b)

J and displaces

thiamin from the tissues

rapidly [Rindi and Perri (1961), DeCaro et al. (1956)].
Some of the PTH in rat tissue is phosphorylated, perhaps to
the diphosphate ester, and the remainder exists in a free form
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[Morita et al. (1968b), Rindi and Perri (1961)].

Free PTH is a strong

competitive inhibitor of purified thiamin pyrophosphokinase [ Johnson
and Gubler ( 1968) J while the diphosphate ester has been shown to
weakly inhibit purified yeast pyruvate decarboxylase [ Witter£ and
Gubler ( 19 7 1) J .

It is not known which site of inhibition accounts for the major
inhibitory effect of PTH on thiamin activity in rat tissue.

Thiamin is

actively transported into cells and accumulates in the cell as the diphosphate ester.

When PTH is added to media which bathes brain

cortex slices [ Sharma and Quastel ( 1965) J or inverted rat intestine
sacs [ Ventura and Rindi (1965), Rindi and Ventura (1967), and
Ventura et al. (1969)], the active transport of thiamin into the cells
is inhibited.

The inhibitory effect of PTH on the phosphorylation of

thiamin in these studies accounted for almost all the inhibition of net
transport of thiamin.
Free thiamin and TMP serve no recognized function in brain
tissue and are considered hydrolysis products of TDP.

Hydroxyethyl-

thiamin (HET) has been identified as an intermediate in the conversion
of pyruvate to AcCoA [Krampitz ~al. (1958, 1959, 1961)] and has
been found in rat, rabbit and dog tissues [Morita et al. (1968c)].

To

date, the brain levels of free thiamin, the mono-, di-, and triphosphate
esters of thiamin have been determined in normal [Rindi and Guiseppe
(1961)] and in thiamin-deficient rats [DeCaro ~al. (1961)].

There
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have been no reports in the literature of HET levels in thiamin-deficient
or thiamin-antagonized rats.

The HET levels in the brain have been

inadvertantly included in the thiamin as says, in which assays alkaline
K 3 Fe(CN)

6 was used as the oxidizing agents for thiamin [ see Rindi

and Guiseppe ( 1961), De Caro et al.

( 1957), 1958, 1961), Rindi

~

al.

(1963), Lewin and Wei (1966), Dreyfus (1961), Myint and Houser (1965),
and McCandless and Schenker (1968)].
The rate of accumulation of PTH in the brain of PTH-treated
rats and the simultaneous rate of displacement of thiamin from the
brain of these PTH-treated rats, that receive appropriate daily doses
of PTH or PTH plus thiamin which cause polyneuritic conditions to
develop in the rat, has not been conclusively determined to date.

A

preliminary study of the effect of a wide range of doses of PTH over
varying treatment periods in rats [De Caro et al. ( 1954, 1958) J
indicated that thiamin was displaced more rapidly from the brain in
the PTH-treated rats than in the thiamin-deficient rats.
Using improved fluorometric techniques, Morita et al. (1968b)
reported that a single intraperitoneal (i. p. ) dose of PTH ( 1 mg/ 100 g
rat) decreased the thiamin level in the brain of eighteen day thiamindeficient and normal rats in just 24 hr after treatment, 33% and 67%
respectively, of normal rat brain levels.

The PTH was rapidly dis-

placed from the brain by oral or i. p. administration of thiamin.

Rindi

and Perri (1961) did not determine the brain thiamin level in rats that
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received 33 ug of thiamin and 210 ug of PTH orally, but the PTH levels
in the brain after twenty days of treatment were close to the brain
thiamin levels reported for normal rats [Rindi and Guiseppe (1961)].
Gurtner ( 1961) treated rats daily with higher levels of thiamin and PTH
than used by Rindi and Perri ( 1961) and reported that the brain levels of
TDP in the PTH-treated and thiamin-deficient rats after twenty-nine
days of treatment were not significantly different, although only a small
percentage of the thiamin-deficient rats did experience extreme neurological symptoms.

All of the PTH-treated rats experienced extreme

neurological symptoms.

The level of PTH in these rats was not

determined.
Rindi et al. (1963) reported that the TDP levels were not
significantly affected in the brains of rats when treated with the same
and higher levels of 0TH plus thiamin as used by Gubler (1961).
The composition of the diet, level of thiamin in the diet,
amount of antagonist, route of administration of the antagonist and
thiamin, and age of the treated animals are factors which may significantly affect the level of thiamin or antagonist in animal tissue.

For

these reasons, it is difficult to compare directly results reported by
different investigators of thiamin or thiamin-antagonist levels in
tissue at a particular period of treatment.

Therefore, in order to

more clearly evaluate the effects of thiamin insufficiency on the central
nervous system, a comparative analysis of the various forms of thiamin
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in the brain of thiamin-deficient and thiamin-antagonized rats were
determined at weekly intervals up to the terminal stages of treatment.
Such a comprehensive investigation would allow one to compare
directly the levels of thiamin and its derivatives in the brain of control rats to the corresponding level in the brain of thiamin-deficient
and thiamin-antagonized rats on the same treatment day by the same
oxidation procedure.

Since no satisfactory method had been reported

for the analysis of the various forms of thiamin in rat tissue, specific
assays based on procedures reported by Morita et~- ( 1968a, 1969)
were developed and were used for the determination of free thiamin,
TDP

+ TTP 1 ,

total thiamin 2 , and HET in control, thiamin-deficient,

OTH-, and PTH-treated rats.

The PTH levels will be determined in

the PTH-treated rats also.
From this study one can determine if there is any correlation
between the physiological effects of treatment, i.e., weight loss and/
or convulsions, and the respective levels of thiamin derivatives in the
brain.

Also, the levels of the thiamin derivatives, as well as the PTH

levels in the case of the PTH-treated rats, should correlate with, and
hence make more meaningful, the oC -keto acid dehydrogenase activity
1 The di- and triphosphate esters of thiamin are not separated
from each other by this assay.
2

The total thiamin assay includes free thiamin, the mono-,
di-, and the triphosphate esters of thiamin. HET is determined in a
separate assay.
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in the brain of thiamin-deficient and PTH-treated rats [ see Gubler
(1961), Bennett et al. (1966), McCandless and Schenker (1968)].

LITERATURE REVIEW
Thiamin, HET, 0TH,
and PTH Assays
The most sensitive, accurate, reproducible assay for thiamin
in animal tissue is the thiochrome assay [Jansen (1936), see Metzler
(1960) for review].

This assay is based on the fact that thiamin can

be oxidized, under certain conditions, to thiochrome, a water soluble
moiety that exhibits a rather unique fluorescent spectra.

When thio-

chrome is extracted into isobutyl alcohol and subsequently excited with
365 nanometer (nm) light, an intense blue fluorescence can be monitored at 436 nm with a fluorometer.

The extraction of the thiamin

from an aqueous media into the alcohol is a purification step and also
increases the intensity of the fluorescence.

The limit of sensitivity of

this method is about 0. 02 ug thiamin per assay [Morita et al. (1968a,
1969)].

Since the phosphate esters of HET, 0TH and PTH respond in

a very similar fashion to the corresponding phosphate esters of
thiamin, as far as chromatographic separation is concerned, it is
necessary to use selective oxidizing agents when analyzing mixtures
of thiamin, HET, and PTH.

On a molar basis, the relative fluorescent

intensities of thiamin, HET and PTH, when oxidized with alkaline
K3Fe(CN)

6

[Association of Vitamin Chemists ( 1951)] at the above
11

12
excitation and emission wavelengths, is 100, 100 [ Morita et al.
(1968)], and 14 [Sealock and White (1949)

J

respectively.

However,

cyanogen bromide (CNBr) and 1% HgC1 2 are very selective oxidizing
agents and will oxidize thiamin to thiochrome but will not oxidize
HET [Morita et al. (1968c, 1969)].

Also it has been found that the

CNBr oxidation procedure is completely selective for thiamin in the
presence of PTH [Fujiwara and Matsui (1953)].

It was found that in

thiamin and HET mixtures, thiamin could be selectively destroyed by
incubation of the mixture in base with a trace of HgC1 2 [Morita et al.
(1969)], so that HET could then be oxidized with K 3 Fe(CN)6 to thiochrome.
assay.

It has not been reported whether PTH interferes with this

The 1% HgC1 2 oxidant is comparable to the CNBr oxidant as

far as selectivity is concerned [Morita et al. (1969)], but the 1%
HgCl2 is easier to prepare and the CNBr reagent is stable for only
3 hr at room temperature [Fujiwara and Matsui (1953)].
0TH does not form a thiochrome analogue or any fluorescent
product when treated with alkaline K3Fe(CN)6 [Association of Vitamin
Chemists (1951)] or with 1% HgC1 2 [unpublished work in Dr. Clark
Gubler' s lab].

The O atom in the 4' position of 0TH will not react

with the C-2 electron pair and allow a conjugated system to form as
in thiochrome or pyrichrome 3 .

The only successful assay for 0TH in

animal tissue that has been reported is a radioactive assay using
3 Pyrichrome is the fluorescent compound produced when
PTH is oxidized with alkaline K 3 Fe(CN)6 [Fujita~ al. (1952)].
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35 S-OTH [Rindi et al. (1963)].

The labelled antagonist is extracted

from the tis sue, purified and chromatographically isolated according
to the procedure described for thiamin [Rindi and Guiseppe (1961)].
Thiamin [Henessy and Cerecedo (1939), Association of
Vitamin Chemists (1951), Rindi and Guiseppe (1961)], HET [Shiobara
et al.
---

--

--

(1965), Morita et al. (1969)], 0TH [Rindi et al. (1963)] and

PTH [Rindi and Perri (1961), Morita et al. (1968a, b)] are easily
extracted from tissue with aqueous acids and can be recovered in
excellent yield from ion exchange columns [Association of Vitamin
Chemists (1951), Rindi and Guiseppe (1961), Morita et al. (1968a,
1969), Rindi ~ al. ( 1963)].

Thiamin monophosphate, TDP and TTP

have been isolated in a quantitative manner [Rindi and Guiseppe (1961)]
by selective elution from a Dowex 1 and an Amberlite CG-50 column.
This procedure, however, requires large amounts of tissue and the
purification step prior to column treatment requires a cholesterol
stearate -treated charcoal column that is difficult to prepare [ unpublished work in Dr. Clark Gubler's lab].
A quantitative paper chromatographic separation of thiamin
and its phosphate esters has been reported [Lewin and Wei (1966)].
Itokawa and Cooper ( 1970b) reported that thiamin and its phosphate
esters could be rapidly separated on Sepraphore strips by electrophoretic techniques.

In both cases, after separation, the thiamin

compounds were eluted from the support media and were then oxidized
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to thiochrome with alkaline K 3 Fe(CN) 6 .

However, both of the above

techniques require purification steps prior to spotting the thiamin
compounds on the paper or Sepraphore strips when the thiamin is
extracted from tissue.

Thiamin Administration
Since the competitive nature of PTH and 0TH with thiamin is
so important in studying the effects of thiamin deficiency, Gubler
(1961) reported a systematic injection procedure to study the effects
of these inhibitors on the metabolism of pyruvate and oC. -ketoglutarate
in rat tissues.

Gubler (1961) used a 200/1 ratio of OTH/thiamin and

a 5/1 ratio of PTH /thiamin in his inhibitor studies along with a
thiamin-deprived group.
diet.

All three groups were fed a thiamin-deficient

It was found that a subcutaneous (s. c.) injection of 10 ug of

thiamin/100 g body weight causes the rats to grow at a maximum
rate (see Figure 1) with a minimal effective amount of thiamin in the
tissue stores and allows for a convenient and practical amount of
antagonist to be used.

The ratio of 0TH to thiamin is such that the

0TH effect on the rats can be achieved within about four weeks, and
polyneuritis develops in the PTH-treated rats in about three weeks.
Some investigators administer the thiamin and antagonists orally
ad libitum.

This becomes a significant additional variable, since

the level of intake of thiamin and the antagonist would be affected by
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Fig. 1. - -Minimum levels of thiamin required to maintain
the growth rate of rats Scott and Griffith ( 1957) .
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anorexia in all groups [Gubler and Bethsold (1962), Bitter et al. (1969),
and Bai et al. (1971)].
Thiamin Distribution in Animals
Thiamin, taken in the diet, is distributed in the body in the
manner indiacted in Figure 2.

Dietary thiamin is stored in the tissue

for further use or distributed in the blood to other areas in the body
where the requirement for thiamin is greater br is excreted in the
urine [Ziporin ~al. (1964), Balaghi and Pearson (1966a, b)].

Dietary Vitamin

i
TissJ

Other Body Constituents

Blood

Pool _________ - - - - - " - - - - - -

~

Urine
[Pearson (1967)]
Fig. 2. --Thiamin distribution in an animal

The distribution of thiamin in rats is about the same as in
humans [Balaghi and Pearson ( 1966a), Ariaey-Nejad et al. ( 1970)].
About 85% of an oral dose is absorbed by the small intestine by active
transport [Ventura et al. (1969), Pearson (1967)].

The vitamin is

concentrated in and transported into the cells by phosphorylation
according to Sharma and Quastel ( 1965) who used rat brain cortex.
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artherosclerotic lesions as well as opisthotonus and ataxia.

It is

interesting to note that the transketolase activity of the brains of both
strains did not decrease from the normal controls.

The one strain

showed no pathological symptoms.
As another example:
We have failed to produce nerve degeneration in pigs by
inducing thiamin deficiency. This does not mean that thiamin
deficiency can under no circumstances cause nerve degeneration
in the pigs nor that the results of these experiments necessarily
apply to man. It has been shown repeatedly that various animals
differ in their vitamin requirements . . . It should be pointed out
that the most convincing studies indicating that deficiency leads
to morphological alterations in the nervous system have been
carried out in pigeons [Wintrobe (1942a)].
In the above paragraph Wintrobe refers to studies with
several hundred pigs over a period of six years.

The thiamin defi-

ciency of the pigs was clinically determined by urine thiamin and
blood pyruvate levels of the living animal and tissue thiamin levels
at death.

Forced exercise during the deficiency period brought on a

cyanotic condition, collapse, brief convulsive movements of the hind
quarters and finally death.

The only overt signs of deficiency in the

nonexercised pigs were recurrent vomitting and anorexia.

The pigs

were fed orally with crystalline vitamin preparations as opposed to
yeast preparations used earlier [Wintrobe et al. (1942b)].
Rats fed a thiamin-deficient diet begin to lose weight in about
two weeks of treatment due to a decreased food intake.

After four

weeks the rat is below his original weight, shows curvature of the
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spine, is extremely weak and emaciated.

Usually the thiamin-deficient

rat dies within four to five weeks of treatment.

Unless the rats survive

for extended periods or are fed a low thiamin diet for extended periods,
the thiamin-deficient rats usually do not show signs of polyneuritis
[publer (1961), Dreyfus (1961), Park and Gubler (1968), Robertson et
al. (1968), Bitter et al. (1969)].

The overt pathological symptoms

associated with thiamin deficiency in experimental animals prompted
Dreyfus (1958, 1961) to quantitate, histochemically, the thiamin distribution in the brain of normal as well as thiamin-deficient rats.
conclusion was that he could find "no correlation between

His

brain

tissue thiamin levels and the susceptibility of certain parts of the
neuraxis to vitamin B 1 deprivation."
Electron microscopic studies on the thiamin-deficient rat
brain are not conclusive [ Collins ( 1967), Tellez and Terry ( 1968),
and Robertson et al. ( 1968) J as far as the major site of tissue destruction is concerned.

The earliest effects seem to occur in the glial cells

in the brain stem.

Robertson and Manz ( 1971) used the penetration of

labelled albumin into brain tiss,.1e as a measure of tissue destruction
in rats on a thiamin-deficient diet.

They were able to show that during

the early stage of thiamin deficiency when the glial cells of the brain
stem were only swollen, no albumin penetrated the blood-brain barrier.
Later, when frank necrosis was observed in the membranes, the dyelabelled albumin penetrated into the brain.

The clinical symptoms of
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thiamin deficiency in the rats correlated well with the histological
examination of the brain stem.

Estimation of the brain tissue damage

correlated with the entrance of the dye into the brain tissue.

When

the animals showed signs of ataxia, tremors and loss of righting
reflex, the necrosis of the brain stem membranes was observed, and
at this time the fluorescent label was observed in the brain tissue.

It has not been shown that the transketolase activity of
certain areas of the brain is a better index of thiamin depletion than
is the pyruvate decarboxylase activity.

The transketolase activity in

thiamin-deficient rats in the brain stem, cerebral cortex, and cerebellum is decreased more than the pyruvate dehydrogenase activity
in these regions [Dreyfus and Hauser (1965), Dreyfus 1965), McCandless and Schenker (1968)].

However, only the pyruvate dehydrogenase

activity is restored toward normal values with thiamin repletion.

The

transketolase activity of the brain in thiamin-deficient rats is not
increased by i. p. injections of 10 ug of thiamin in a four and a half
to five week thiamin-deficient rat [McCandless and Schenker (1968)],
although this treatment cured the ataxic condition of the rats.

This

fact suggests that the brain transketolas~ activity is not directly involved in the effects of thiamin deficiency.
The Effects of 0TH and
PTH on the Rat
Thiamin is distributed in rats by active transport across cell
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membranes [Sharma and Quastel ( 1965 )] .

The effect of this transport

process is to concentrate the thiamin in the cell as TDP against a concentration gradient, so that TDP will be in high enough concentration
in the cell to activate its apoenzyme.

The process of active transport

of thiamin across the intestine was suggested by Polin~ al. ( 1963).
Sharma and Quastel ( 1965), using rat brain cortex slices, and Ventura
and Rindi (1965), Rindi and Ventura (1967), Ventura et al. (1969),
using inverted rat intestine sacs, reported that thiamin is actively
transported into the cell where it accumulates in the phosphorylated
form.

The first four investigators showed that PTH, a thiamin analog ,

inhibits the accumulation of thiamin in the cell.

Ventura and Rindi

(1965) and Rindi and Ventura (1967) show that 0TH does not inhibit
this process at twice the concentration at which PTH inhibits the process.

Sharma and Quastel ( 1964) and Rindi and Ventura ( 1967) found

that PTH inhibited the phosphorylating action of thiamin pyrophosphokinase at the same concentrations at which inhibition of the active
transport takes place.

It had been determined that PTH inhibited

purified thiaminokinase in rat liver [Mano and Tanaka (1960)], rat
brain [Johnson and Gubler (1968)], pig brain [Peterson (1970)], and
a purified liver thiaminokinase preparation [Koedam and SteynParve' (1960), Eich and Cerecedo (1954)].
Wooley ( 1951) sugges ted that PTH may be pho sph orylated to
the diphosphate in vivo and that as the diphosphate may act as an
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inhibitor of TDP enzymes either by inhibiting the union of TDP with
its apoenzyme or by inhibiting the formation of TDP.

Koedam and

Steyn-Parve' (1960) showed that PTH acted as a very weak inhibitor
of pigeon pyruvic dehydrogenase when competing with TDP for the
apoenzyme.

This same type of competition was also reported for

yeast decarboxylase.

Koedam and Steyn-Parve' found that PTH and

0TH or their respective monophosphate esters do not inhibit yeast
carboxylase activity, even if the preparation is treated with the antagonists before the TDP cofactor is added.

However, PTH and 0TH

diphosphates can inhibit the yeast carboxylase if added to the preparation before the TDP cofactor.

If TDP is added first, the antagonists

do not exert any effect.
When the antagonists were tested as inhibitors of the pyruvate
dehydrogenase activity of pigeon breast and heart muscle, it was found
that free PTH and free 0TH did not affect the amount of acetoin formed
in this preparation [Koedam and Steyn-Parve 1 (1960)].

The diphos-

phates of 0TH and PTH, however, did inhibit the enzymatic reaction
even if the antagonists were added to the preparation after TDP.

It

was found that 0TH diphosphate was a much stronger inhibitor of
this pyruvate dehydrogenase activity than was PTH diphosphate.
Witter£ and Gubler (1971) found that the diphosphate ester of PTH
possessed one-third of the affinity of the diphosphate ester of 0TH
for yeast pyruvate decarboxylase.

Morita et al. ( 1968b) reported
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that 93, 90, 77, and 71% of the PTH content of the heart, skeletal
muscle, liver and brain respectively of a rat injected with a large
dose of PTH, was in the phosphorylated form and that this resulted
in a rapid loss of thiamin from the tissue.

Rindi and Perri (1961)

indicated that less than 1% of the PTH in the brain of PTH-treated
rats was not phosphorylated.
There have been a few reports in the literature concerning
the effect of PTH treatment on the distribution of the thiamin phos phate esters and free thiamin in rat brain.

Rindi and Sciorelli (1970)

stated that PTH may exert its effect on the central nervous system of
the rat because of the very rapid rate of depletion and extent of re moval of thiamin phosphates from the brain.

The initial per cent

increase of free thiamin in the brains of rats receiving O. 6 u mole
of PTH intracerebrally (i. c.) or when fed a thiamin-deficient diet,
was not felt to be the cause of the neurological disturbances characteristically observed in terminal PTH-treated rats and which sometimes
accompanied thiamin deficiency treatment.

Rindi et al. ( 1970) and

Rindi and Sciorelli (1970) found that an i. c. injection of 0. 25 mg
(0. 6 u mole) of PTH caused a 40% decrease in total thiamin phos phates in the rat brain by the seventh day after the injection.

Also

the free thiamin and phosphorylated forms of thiamin increased in the
brain when thiamin was orally administered seven days after the i. c.
injection of PTH.

Rindi et al. ( 1970) reported that seven days after
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the single i. c. injection of O. 25 mg of PTH, the total phosphate level
in the brain decreased to only 60% of the control levels.
Twenty-four hours after injecting (i. p.) 1 ug of 0TH into rats
that had been on a thiamin-deficient diet for fifteen days, the amount
of TDP as well as the total thiamin level in the brain was not affected.
These investigations showed that the highest total 0TH levels in the
brain of the rats was only one-seventh of the total thiamin levels
[Rindi et al. (1963)].

Since 0TH probably exerts its competitive in-

hibitory effects via the diphosphate ester [Johnson and Gubler (1968),
Koedam and Steyn-Parve' ( 1960)], the injection of 0TH alone, as
Rindi et al. (1963) did, would have a greater inhibitory effect than
would the injection of 0TH plus thiamin.

Rindi

~

al. ( 1970) found that

only a 19% drop in three days of total thiamin phosphates was observed
when O. 2 mg of 0TH was injected directly into the brains of rats.

This

dose is 320 times the amount of 0TH that is found in the brain 24 hrs
after a 1 mg i. p. injection of 0TH [Rindi ~ al. ( 1963 )] .
Rindi et al. (1963) showed that 0TH, when injected into the
rat, was phosphorylated to the di phosphate in liver, heart, and brain
tissue.

Since very little 0TH entered the brain, only very small amounts

of 0TH diphosphate were found in that organ.

This may explain why

OTH-treated rats do not develop polyneuritis.

The level of 0TH in the

tissues depended on the thiamin level already in the tissues and on the
OTH/thiamin ratio in the dose administered.

The rat is able to
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eliminate 0TH from the body tissues more rapidly than PTH; 24 hrs
after a single i. p. injection of 1 mg of 0TH into normal rats, the
liver 0TH level had decreased 98% and the heart 0TH level had dropped
by 75%.
The most striking characteristic of OTB-treated rats is the
poor weight gain experienced at the beginning of the treatment.

The

OTH-treated rats usually gain less than 5 g the first week of the treatment [Gubler (1961), Gubler and Bethsold (1962), and Bitter et~.
(1969)].

The thiamin-deficient and PTH rats show a weight gain about

equal to or slightly less than the control rats for the first ten days of
the treatment.

Bai

~

al. ( 1971) correlated the inability of the OTH-

treated rat to gain weight after the first day of treatment with a SO%
decrease of transketolase activity in the gut of OTH-treated rats.

The

activity in the gut of thiamin-deficient and PTH-treated rats does
decrease during treatment but does not decrease as much nor as consistently or as rapidly as in the OTH-treated rat.

They concluded

that "the anorexia would appear to be due to some local lesion in the
gut . .

II

The extremely weak and emaciated condition of the terminal
thiamin-deficient, OTH- and PTH-treated rats is not necessarily the
reason for the death of the animals.

Thiamin-deficient and PTH-

treated rats that are force fed daily 8 g of thiamin-deficient diet show
an almost normal weight gain up to three days before death.

The
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force fed OTH-treated rats gain weight at about one -half the rate of ·
the control rats since they receive one -half (4 g) the amount of food.
OTH-treated rats bloat and die at the beginning of treatment when
force fed 8 g of diet per day.

Although the PTH-treated rats that are

force fed die at the same time as do rats fed ad libitum, the thiamindeficient and OTH-treated rats die one-third sooner than the ad libitum
fed rats [Bitter et al. (1969)].

The thiamin levels in the force fed

rats that are terminal has not been determined.

Therefore, the reason

for the earlier death of the thiamin-deficient and OTH-treated rats is
still s pe cul a ti ve .
PTH and 0TH treatment affect the heart rate in rats to a
greater extent than thiamin-deficiency treatment does.

The 0TH

arid

PTH treatment cause a 47 and 58% decrease respectively in the rat
heart rate, while the thiamin-deficient treatment causes only a 28%
decrease from the average control levels [Cheney, Gubler and Jaussi
(1968)].

According to Gubler (1961) and Gubler and Bethsold (1962)

the pyruvate metabolism in the rat heart is affected to a greater extent
than is the o<. -ketoglutarate metabolism in thiamin-deficient, OTHand PTH-treated rats (see Table 1).
In vitro enzymatic assays in this dissertation are intended to
reflect the activity of the appropriate
plex in vivo.

()C

-keto acid dehydrogenase com-

Cellular control mechanisms in the intact animal should

be recognized in this type of a study so that the in vitro assay of the

TABLE 1
PER CENT DECREASE OF CX:: -KETO ACID DEHYDROGENASE ACTIVITY, IN VITRO,
OF TERMINAL THIAMIN-DEFICIENT, OTH- AND PTH-TREATED RATS

Tissue
Brain

oC-Ketoglutarate Treatment

Pyruvate Treatment
PTH

Th Def

50 {G)
30 {Ba)
75 {H)

O {G)

{G)
{GB)
{Bb)
{Bb)

50 (G)
60 {GB)
82 {H)

20 (G)
40 (GB)

Th Def

0TH

25 {G)
30 {M)
72 {R)

O {G)
0 {Bb)
0 {Bb)

{ 1)
{2)

30
60
( 1) 74
(2) 51

Liver

60 {G)
60 (GB)
75 (R)

Heart

30 {G)
30 (GB)

70 (G)
70 (GB)

60 (G)
60 {GB)

Kidney

54 (G)
70 {GB)

50 (G)
50 {GB)

70 (G)
70 {GB)

{G)

(GB)
{Ba)
{Bb)
{H)
{M)
{R)

= Gubler {1961)
= Gubler and Bethsold ( 1962)
= Bennett et al. { 1966)
= Bennett et al. {1969)
= Holowach et al. { 1968) (mice)
= McCandless and Schenker { 1968)
= Reinauer et al. { 1968)

0TH
{ 1)

{2)

0 {G)
0 {Bb)
0 {Bb)

0
0
{ 1) 28
{2) 0

PTH

45 {G)
60 {H)

{G)
{GB)
(Bb)
(Bb)

O {G)
0 {GB)
54 {H)

24 (G)
16 {GB)

36 (G)
30 (GB)

0 (G)
O (GB)

56 (G)
50 {GB)

0 (G)
0 (GB)

40 {G)
40 {GB)

(1) = Low-fat diet
(2) = High-fat diet

N
-.J
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enzymatic activity will be meaningful.

Wieland et al. (1971) reported

that pyruvate dehydrogenase from rat heart and kidney is activated by
addition of Mg++.

The pyruvate dehydrogenase activity is controlled

by a Mg++ -ATP dependent kinase and phosphatase enzymes.

Phos-

phorylation of pyruvic dehydrogenase causes inactivation while higher
levels of Mg++ activates the phosphatase enzyme and thus activates
the pyruvate dehydrogenase enzyme.

The pyruvate dehydrogenase

complex from heart muscle, kidney, liver and brain are interconvertible.

Fasting of rats for 24 hr

causes the pyruvic dehydrogenase

activity in the heart and kidneys to decrease to 15% of control rats.
Refeeding of the fasted rats with glucose restores all the pyruvate
dehydrogenase activity in 2 hr .
This Mg++ -ATP-dependent control system must be recognized
in order to determine the state of the pyruvate dehydrogenase complex
in vivo.

Gubler (1961), Gubler and Bethsold (1962), Bennett et al.

(1966), and Reinauer ~al. (1968) used Mg++ salts in their assays and
did not report the effect of withholding Mg++ from the assay, i.e., did
not observe the extent to which pyruvate dehydrogenase exists in the
inactivated form in tissue preparations from treated rats or mice.
The above mentioned investigators probably were measuring the
activity of the active form of the enzyme so would be observing only
the effect of the TDP levels in the tissue on the activity of the pyruvate
dehydrogenase.
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Recent reports by Bennett et al. ( 1966) and Holowach et al.
(1968) seem to confirm Gubler's results concerning the effect of PTH
on rats as far as inhibition of pyruvate metabolism in the brain is
concerned.

The per cent inhibition by PTH of pyruvate dehydrogenase

was 30, 75, and 50% inhibition according to Bennett et al. ( 1966),
Holowach et al. (1968) and Gubler (1961) respectively (see Table 1).
Holowach et al. (1968) found a normal pyruvate level in liver when the
tissue showed a 75% decrease in pyruvate utilization, and concluded
that the glucogenic pathway may utilize the extra pyruvate.

The

finding of an accumulation of o<: -ketoglutarate in the brain of PTHtreated mice associated with a 50% decrease in c<: -ketoglutarate dehydrogenase activity coincides with Guo's (1970) results, insofar as the
accumulation of cl -ketoglutarate is concerned.

Guo ( 1970) reported

that in the brain of thiamin-deficient, OTH- and PTH-treated rats,
"( -aminobutyric acid, the intermediate moiety in the shunt pathway
was not significantly altered.
of glutamate

This pathway involves the conversion

- ' ¥ -aminobutryic a c i d ~ succinate and thus by-

passes the oC -ketoglutarate TDP-requiring oxidation pathway.
the "glutamate-

Also

Y -aminobutyric acid-transaminase and succinic

semialdehyde dehydrogenase activities in this pathway were not
altered . . . " [Gubler ( 1968)] in the brain of thiamin-deficient, OTHand PTH-treated rats.
Holowach et al. ( 1968) found that, although transketolase
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activity in the brain and liver of PTH-treated mice decreased more
than 50%, administration of 1 mg of thiamin to deficient animals 5 hr
prior to killing did not cause the transketolase activity to rise to
control levels.

The administration of 1 mg of thiamin to the terminal

thiamin-deficient mice did cause the

o(

-keto acid dehydrogenase

activities to increase 60% in the brain and the liver.

A similar result

was observed by McCandless and Schenker (1968) in the brain of terminal thiamin-deficient rats, as previously mentioned.

Effect of Thiamin Deficiency and Thiamin
Antagonist Treatment on Adenosine
Triphosphate Levels
In order to describe the effects of thiamin insufficiency in
rats, a discussion of the level of adenosine triphosphate (ATP) is of
great concern.

If the drop in

,:,(, -keto acid dehydrogenase activity

during a thiamin insufficiency condition is of physiological importance,
i.e. , contributes to the death of the animal, one would expect to find
a drop in the ATP levels in these tissues somewhat proportional to
the decrease in o<. -keto acid dehydrogenase activity.
McCandless and Schenker (1968) and Inoue~ al. (1970)
reported that brain ATP levels are not below normal, even in severely
ataxic thiamin-deficient rats, which suggests that the glycolytic pathway and tricarboxylic acid cycle are producing sufficient energy for
the tissue.

However, it should be noted that even in undernourished

infant rats, which have lost 41% of their body weight, the brain ATP
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levels are normal [Thurston et al. ( 1971)].

The brain normally

utilizes glucose as the main energy source, but can utilize ketone
bodies produced by the liver, in addition to the small amount of
glucose supplied by the liver when the carbohydrate intake levels
are insufficient [Cahill (1970)].
Schenker et~. (1971) reported an increase in plasma ketone
bodies in pair fed and thiamin-deficient rats when compared to controls.
The thiamin-deficient rats, however, maintained about the same level
of plasma ketone bodies as did the pair fed animals.

Holowach et al.

(1968) found that, in PTH-treated mice, the brain ATP and creatine
phosphate levels were normal.

This condition is difficult to explain.

The levels of ATP in the brain are about 3 nanomoles/g wet tissue
[McCandless and Schenker ( 1968)].

According to Rindi and Guiseppe

(1961) and DeCaro et al. (1961), thiamin levels in the normal rat brain
are about 8 nanomoles /g wet tissue.

The turnover of TDP in vivo is a

constant significant drain on the ATP since thiamin diphosphate is
constantly being formed by the following reaction:
thiamin _ _ _ _ _ _
A_T_P_ _ _ _ __
thiamin pyrophosphokinase
Mano and Tanaka ( 1960) .

TDP

+ adenosine

monophosphate

When the thiamin level is significantly

reduced in tissue, less ATP is required for phosphorylation of thiamin,
hence a correspondingly small deficit of ATP production in the cell
might be masked by the ATP which is spared by the low thiamin levels.
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Effects of High-Fat Diets
The effect of a high-fat diet in rats has been studied by Evans
and Lepkousky (1929), Salmon and Goodman (1937), and Scott and
Griffith ( 1957).

Usually a high sucrose, low-fat diet contains 69%

sucrose, 20% protein (casein), 5% salts, and 10% fat [Scott and
Griffith (1957), Gubler (1961), Bennett~ al. (1969)].

A high-fat,

low-carbohydrate diet reverses this percentage of sugar and fat in
the diet [Dr. Clark J. Gubler, unpublished data] or sucrose is left
out of the diet and the fat is increased to over 40% [Scott and Griffith
(1957)], or 30% [Jones (1962), Bennett et al. (1969)] of the diet by
weight.

These diets contain crystalline or pure vitamins and minerals,

purified fats and proteins.

It is reported that the high-fat diet, as

opposed to a high-carbohydrate diet, prevented the normal thiamin
deficiency response.

Balaghi and Pearson (1966b) determined that

the thiamin requirements of rats which receive adequate thiamin by
injection and are fed a high-fat diet, are lower than those of rats
fed a low-fat, high-carbohydrate diet.
the following observations.
2-

14

C-thiamin daily.

2

The rats were injected with 50 ug of

Half of the rats received a high-fat diet and half

received a low-fat diet.
14 co

This conclusion was based on

The rats fed a high-fat diet expired 15% less

than did the rats fed a low-fat diet.

Although .the chromato-

graphic pattern and level of radioactive metabolites was identical in
both groups of rats, the level of urinary thiamin was 60% higher in the
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rats fed a high-fat diet.

The rate of loss of the 2-

14

C-carbon of

thiamin is a measure of the rate of catabolism of thiamin [Balaghi
and Pearson (1966a)].

The fact that more thiamin is excreted in the

urine of the rats fed a high-fat diet is an indication that the thiamin
excreted represents excess thiamin not required £or metabolism of
pyruvate and '-" -ketoglutarate.

A similar study has not been run on

thiamin-deprived or antagonized rats.
Jones (1962), using a purified diet, reported that a high-fat
diet produced a striking effect only on the OTH-treated rats and did
not affect the PTH-treated and thiamin-deficient rats .

The OTH-

treated rats on a high-fat diet gained weight for ninety-eight days at
the same rate as the control rats.

The 0TH group on a low-fat, high

carbohydrate diet began losing weight on the second day, experienced
diarrhea and died on treatment day 30.

No enzymatic tests were

performed on these rats.
Bennett, Jones, and Nelsen ( 1969) confirmed the above report
but also determined enzymatic activities of OTH-treated rats fed a
high- and low-fat diet.

The enzymatic activities that were determined

include pyruvate dehydrogenase, ,x. -ketoglutarate dehydrogenase and
transketolase activity of brain and liver tissue.
activity of the blood was also determined.

The transketolase

None of the mentioned

enzymatic activities of the brain in the OTH-treated rats on a highor low-fat diet were different from control rats.

Pyruvate

~

tabolism
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in the OTH-treated rats on the high-fat diet was depressed SO% in the
liver when compared to rats fed the same diet with no OTH-treatment,
while the liver pyruvate dehydrogenase activity in OTH-treated rats
fed a low-fat diet was depressed to 36% of the control values.

The

ex -ketoglutarate dehydrogenase activity in the liver of OTH-treated
rats fed the high-fat diet was not significantly different from the control
rats fed the high-fat diet with no 0TH.

The same activity in the liver

of OTH-treated rats fed a low-fat diet was 72% of the normal control
values.

The transketolase activity of the liver in the OTH-treated

rats fed the high- and low-fat diet was depressed to 16% of the control
values.
Datta and Racker ( 1961) reported that 0TH diphosphate has a
higher affinity for the transketolase apoenzyme than does TDP, a fact
which may explain a significant loss of transketolase activity.

Appar-

ently the transketolase activity is not involved significantly in the
normal maintenance of these tissues since it is lower in the blood of
OTH-treated rats fed a high-fat diet than in the blood of OTH-treated
rats fed a low-fat diet.

Jones (1962) and Bennett et al. (1969) con-

cluded that OTH-treatment symptoms are alleviated by AcCoA units
made available to the citric acid cycle from the breakdown of fatty
acid units, thus bypassing the pyruvate conversion step.

"Outwardly

it appeared as if the fat had completely substituted for the loss of
thiamin pyrophosphate." If the more available supply of AcCoA units
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in the high-fat diet is the reason why the OTH-treated rats are not
affected, one might expect the thiamin-deficient and PTH-treated
rats on a high-fat diet to respond in a similar fashion.

Gubler (1969)

and Jones (1962), found that a high-fat diet provided only a slight
amount of thiamin-sparing action in the thiamin-deficient and PTHtreated rats.
This anomaly can be explained if it is assumed that the impaired

c(

-keto acid dehydrogenase activity in the brain is not stimu-

lated by the high-fat diet.

It should be remembered that in the case

of the thiamin-deficient and PTH-treated rat, the brain pyruvate
dehydrogenase activity is decreased from 30 to 72% of normal (see
Table 1 ).

Also in the PTH-treated rat brain, the

oC

-ketoglutarate

dehydrogenase activity is decreased to 30 to 75% of the activity in the
control rat.

According to Gubler (1961) the uC -keto acid metabolism

in the brain of OTH-treated rats is not affected.
In normal rats fed a high sucrose diet and administered
35 so

4

by a stomach tube, the labelled sulfur was incorporated in situ

by the microflora of the caecum into the thiamin molecule.

No signi-

ficant amount of the labelled thiamin was found in the heart and liver
of the host, however [Wostmann and Knight ( 1961 )] .

They concluded

that the thiamin produced by the bacteria in the caecum is not available to the host.

The thiamin produced by the bacteria in the caecum

seems to be bound to large soluble molecules, and, as such, is not
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transported across the intestinal membrane.

This type of tracer

technique has not been used to study the absorption of thiamin from
the intestine of rats fed a high-bulk or high-fat diet.
Meghal and Nath (1965) have shown that a high-fat diet does
cause a several fold increase in the production of thiamin in the
caecum of the rat as compared to rats fed a high-sucrose diet.

It

has been shown that the thiamin-sparing effect of orally administered
sorbitol, a non-nutritive carbohydrate, is dependent on whether the
rat is able to eat its feces [Morgan and Yudkin ( 1957, 1959)].

Simi-

lar studies with rats fed a high-fat diet have not been performed.
At the present time, investigators in Dr. Clark J. Gubler's
laboratory are attempting to correlate the levels of the various forms
of thiamin in the rat liver, heart, and brain to the o< -keto acid dehydrogenase activity of these tissues in thiamin-deficient, OTH- and PTHtreated rats fed a high- and low-fat diet.

Discovery and Identification of HET
Mizuhara ( 1954) reported that in an aqueous solution of pH
8. 4, thiamin would catalyze the decarboxylation of pyruvate and produce acetoin.

Green et al. ( 1942) reported acetoin (acetylmethyl-

carbinol) was formed when acetaldehyde was incubated with pyruvate
and pyruvate decarboxylase preparations isolated from pig heart.
About 84% of the pyruvate utilized was accounted for as acetoin.
Breslow ( 1958) used deuterium exchange technique to show
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that the 2 position in the thiazole ring contained a labile hydrogen.
The -NH

3

+ moiety

position and l

I

in the 4' position, the -CzH 0H group in the 5
4

pyrimidine nitrogen which exchanged

n+ atoms, had

already been ruled out as active carbanionic sites in the 2 carbon
transfer.

The nucleophilic site was, thus, identified.

Surprisingly

enough, Berge! and Todd (1937) had already determined that a methyl
radical in the 2 position of thiamin destroys its biological activity.
Although Breslow felt that the 2 position in thiamin was sufficiently
nucleophilic to react with benzaldehyde, pyruvate and acetaldehyde,
his group was unable to isolate these postulated intermediates.

Bres -

low, however, proposed the following scheme {see Figure 3).
Krampitz et al. (1958) synthesized an active aldehyde thiamin
adduct and found that it was as active as thiamin in a microbiological
assay.

This thiamin adduct was given the trivial name of hydroxy-

ethyl thiamin.

Its systematic name is 3- {4-amino-2-methyl-5- oC

pyrimidyl)-methyl-5-(2-hydroxyethyl)-4-methyl-2{ o( -hydroxyethyl)
thiazolium chloride {HET).

When the synthetic compound was incubated

with pyruvate at pH 8. 4, acetoin was formed [Krampitz et al. (1959)] .
This result confirmed earlier nonenzymatic models.
(1961) isolated HET from mixtures of 1,2
at pH 8. 5 at

so 0 c.

14

c

Krampitz et al.

acetaldehyde plus TDP

The specific radioactivity of the labelled TDP-

active aldehyde adduct was the same as the specific activity of the
original aldehyde.

The dephosphorylated adduct was isolated and
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Fig. 3. --Mechanism of thiamin catalysis in the formation
of benzoin.
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was found to be identical to a synthetic HET preparation.
The benzoyl-thiamin adduct (HBT) that Breslow felt was an
intermediate in the formation of benzoin, was isolated by Mieyal
(1971).

They compared the acidity of HBT with that of HET.

~

al.

Mieyal

(1967) had previously reported deuterium exchange of synthetic HET
without the aid of an enzyme.

When benzaldehyde, acetaldehyde and

thiamin were incubated at pH 8. 1, the principal products were benz oylmethylcarbinol and HET (see Figure 4).

HBT possesses greater

stability than HET and, therefore, is more reactive toward the
carbonyl carbon of acetaldehyde than is HET.

The carbonyl carbon

of acyloins, therefore, must arise from the carbanion bonded to the
2 position of the thiazole ring.

The greater acidity of HBT compared

to HET is due to the well-known fact that the phenyl ring enhances the
acidity of the substituted benzyl H.
When the pH and temperature are adjusted so that HBT does
not show exchange with deuterium at the carbanionic site, the incuba tion of HBT with benzaldehyde will not react to form benzoin or any
other product.

The rate-limiting step of benzoin formation is the

electrophilic attack of benzaldehyde on the HBT carbanion.
Holzer and Beauchamp (1959, 1961) have isolated the 2( oC-hydroxy- oC-carboxyethyl) thiamin intermediate.

When 1- 14 C-

pyruvate and TDP were incubated with purified pyruvate apodecarboxylase, the intermediate TDP-adduct was isolated and was found to be
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Fig. 4. - -Competitive reaction between thiamin, acetaldehyde,
and benzaldehyde [Mieyal et. al. (1971 )] .
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radioactive.

When this radioactive thiamin-adduct was incubated for

longer periods with the pyruvate apodecarboxylase, radioactive CO
was produced.

When 2 -

14

2

C-pyruvate and TDP were incubated with

pyruvate apodecarboxylase, radioactive acetaldehyde was produced.

If the 2-( oC -hydroxy- oC-carboxyethyl)-TDP, or 2-pyruvate TDP.
isolated above, is reduced with HI. radioactive propionate is formed.
These reactions can be summarized as follows:

1-

14

C-pyruvate

+ TDP-apoenzyme

apoenzyme ---•

2-

14

c-pyruvate

14co

-1-

14

C-pyruvate-TDP-

2

+ TDP-apoenzyme

~1-

14

c -acetaldehyde

CO 2
l-

14

c-pyruvate - TDP-apoenzyme HI-1-

14

c-propionate

HET which has been extracted from mammalian tissues with acidic
aqueous solutions [Morita ~ al. ( 1969)] is the protonatE:d. stable
form of the "active aldehyde" -thiamin adduct intermediate.
There is some evidence that indicates that HET may exist
in vivo in an oxidized form as the acetyl-thiamin adduct.

Spectral

evidence indicated that the 2- oG -hydroxyethylthiazolium salt could
be oxidized to the very unstable 2 -acetylthiazolium salt [Breslow
and McNeilis ( 1960)].

+
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( 0)

2 ( oc-hyd roxyet hyl)
thi azol ium salt

2-acetyl thiazol ium
salt

Das et al. (1961) found the pyruvate decarboxylase (E 1 ) isolated from
E. coli, in the absence of CoA and in the presence of pyruvate , ferricyanide ions, H 2 Po- and TDP, will form CO 2 and acetylphosphate.
4
The reaction postulated is as follows:

+

-3

Fe(CN)5

---

L
+

Fe(CN)

-4
6

+

This fact suggests that in the complete enzyme system, in vivo, the
I

HET carbanion is oxidized to the high energy acetyl-TDP compound
prior to transfer of the acetyl group to reduced lipoic acid.

The
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acetyl-TDP adduct is thought to possess a high free energy of hydrolysis of -22 kcal/mole [Nash et al. ( 1958)].

This free energy of hydroly-

sis is higher than any other biological high-energy compound.
Holzer~ al. (1962), using pyruvic oxidase isolated from pig
heart muscle, reported that the amount of
tion of l -

14

14

CO 2 produced in the reac-

c-pyruvate, TDP and pyruvate oxidase, in the absence of

CoA and NAD was directly proportional to the initial TDP levels in the
reaction mixture.

After the initial rapid reaction period, the rate of the

formation of l4co 2 decreased substantially and continued to a constant
rate independent of the initial TDP levels in the reaction.

These facts

suggest that the initial rapid reaction involves the decarboxylation of
pyruvate to HET di phosphate -apoenzyme plus 14 co 2 as follows:
l-

14

c-pyruvate

14co2

+ HET

+ apoenzyme -TDP

-----

di phosphate -apoenzyme

The pyruvate oxidase level is high enough so that an increase of TDP
in the reaction will cause an increase in the reaction rate.

The

second part of the reaction must involve replacement of the HET
diphosphate from the apoenzyme by free TDP so that another molecule
of pyruvate can attack the 2 position of the TDP-apoenzyme complex
and, thus, initiate another rapid decarboxylation reaction as follows:
HET diphosphate-apoenzyme
di phosphate
TDP-apoenzyme
apoenzyme

+ 1-

+ 14co2

14

slow
-TDP-apoenzyme
TDP

C pyruvate

+ HET

rapid
- HET diphosphate -
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When HET diphosphate is incubated with CoA, NAD and pig heart
pyruvate oxidase, the rate of formation of AcCoA was much slower
than the rate observed when pyruvate and TDP is substituted for
HET diphosphate in the above reaction [Holzer~ al. (1962)].
Dr. Clark J. Gubler reported that his unpublished investigations
indicate that the rate of formation of AcCoA from HET diphos phate in the presence of pyruvate dehydrogenase is I /3000 of the
formation of AcCoA formed from pyruvate plus TDP.

Thus, the

protonated "active aldehyde 11 -thiamin adduct seems to be a very unreactive species in in vitro enzymatic assays.

In vivo utilization of

HET has been verified, however.
Shiobara

~

al. ( 19 65) studied the effect of the D and L optical

isomers of HET using rats and rice birds.

His group reported that

both the D and the L form acted as effectively as did thiamin when fed
to these deficient animals.

Holzer and Beauchamp ( 19 61) reported

that the racemic mixture of HET, which they used in quantitatively
determining its activity with pyruvic decarboxylase in vitro was only
43 to 47% as active as TDP.

The rat and the rice bird must be able

to transform the D or the L form to its optically active enantiomer.
Shiobara et al. ( 1966) reported that the D and L isomer of HET, when
fed orally to thiamin-deficient rats is readily converted to thiamin in
the liver.

The liver of the thiamin-deficient rats fed the DL isomers

of HET was homogenized and was used as a source of thiamin for a
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micro -organism culture.

The culture grew at the same rate as one

which received pure thiamin.

That is, the animal was able to convert

DL-HET to thiamin or the microorganisms were able to use the HET
in place of thiamin.

In order to clarify this situation, the same liver

homogenate was assayed for thiamin.

Cyanogen bromide was used as

the oxidant in the assay; this oxidant is specific for thiamin.
not oxidize HET to thiochrome.

It will

The assay showed that thiamin was

increasing in the liver; therefore, DL-HET was being converted to
thiamin in the liver of the rat.

MATERIALS AND EQUIPMENT
Materials
Thiamin chloride hydrochloride, oxythiamin chloride hydrochloride and pyrithiamin bromide hydrobromide were purchased from
Sigma Chemical Company, St. Louis, Missouri.

Minoru Morita of

Japan donated o{-hydroxyethylthiamin chloride hydrochloride as a
gift.
Permutit T or Thiochrome Decalso, a silicate cation exchange
resin, supplied by Fisher Scientific Company, Fair Lawn, New Jersey,
was used to purify the dephosphorylated tissue homogenates.

Amber-

lite CG-50, a polymethylacrylic acid cation exchange resin, chromatographic grade, made by Mallinkrodt Chemical, St. Louis, Missouri.
was used to separate TDP and TTP from TMP and free thiamin.
Taka Diastase, a powdered preparation of Aspergillus oryzae
enzymes, employed as a source of phosphatase activity, was manufactured by Parke Davis and Company, Detroit, Michigan.
The commercial thiamin-deficient diet mix was secured from
Nutritional Biochemicals, Cleveland, Ohio.

The rats also received a

68. 5% sucrose diet, prepared according to Gubler {1961) {see Table 2).
The composition of the diets are similar.
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TABLE 2
THIAMIN -DEFICIENT DIET

Gubler ( 19 6 1)

Composition of Diet
Sucrose
Vitamin-Free Casein
Corn Oil
Salt Mix
Vitamin Mix
Choline

Per cent
68.5
22.0
5.0
4.5
0.22
0.40

Composition of Salt Mix
CaC0 3
KzHP0 4
CaHP0 4 • 2Hz0
MgS04. 7Hz0
NaCl
Ferric Citrate. 6H 2 0
KI
MnS0 4 . HzO
ZnClz
CuS0 4 . 5Hz0

Grams
600.0
645.0
150.0
204.0
335.0
55.0
1. 6
7.6
0.5
0.6

Composition of Vitamin Mix
Inositol
Nicotinic Acid
Pyridoxine HCL (B6)
Riboflavin (Bz)
Biotin
Folic Acid
2-Me -1, 4-Naphtho-quinone
p-Amino Benzoic Acid
Calcium Pantothenate

40.000
0.800
o. 120
0.240
0.004
0.010
0.080
2.000
1. 200
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Deionized water was used in all analytical steps.

All other

chemicals used in this study were reagent grade quality.
The male rats were obtained from Sprague-Dawley Inc. ,
Madison, Wisconsin, and from Geneva Mott, Salt Lake City, Utah.

Equipment
The Turner Fluorometer, Model III. made by G. K. Turner
Associates, Palo Alto, California, was used to determine the
thiamin levels of rat brain.

The Farrand Spectrofluorometer, made

by Farrand Optical Company, New York, was used to establish the
PTH levels in the rat tissue; the spectrofluorometer was equipped
with a Honeywell Elektronic 15 recorder which was used to obtain
fluorometric scans of thiochrome and pyrichrome.
A Corning Model 12 Research pH meter equipped with a
combination electrode, made by Scientific Instruments, was employed
in this study.
The motors used to drive a teflon pestle in the tissue homogenation step were made by Talboys Instrument Corporation, Emerson,
New Jersey, a model 106 Con-Torque power unit, made by Eberback
Corporation, Ann Arbor, Michigan, and a Vari Speed Stirrer, made
by Precision Scientific.

The teflon pestle and glass tissue grinder

were both obtained from Arthur H. Thomas Company, Philadelphia,
Pennsylvania.
Devices used to mix the aqueous solutions and the isobutyl
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alcohol include a Rotary Evapo-mix shaking unit, made by Buchler
Instruments, Fort Lee, New Jersey, and a Vortex Genie mixing
device, supplied by Scientific Industries Inc., New York.
A Servall Refrigerated Automatic Centrifuge was used for
the preparation of the homogenate.

A 4. 25 in. rotor was used.

The wet tissues were weighed on a Mettler microbalance
made by Mettler Instrument Corporation, Highstown, New Jersey.
A Temptroll 152 waterbath, made by Precision Scientific
Company, Chicago, Illinois, was used to provide a constant temperature of 48 to 50°C for incubation.

METHODS
Diet and Injection Schedule
The male Sprague-Dawley rats were placed in individual
stainless steel cages in an air-conditioned room maintained at 72°C.
All the rats had free access to water.

The rats were allowed to eat

Purina Rat Chow ad libitum for four days before introducing them to
the particular diet and injections.

Day zero was the day on which the

rats were started on the thiamin-deficient diet and were injected with
the appropriate supplements.

The commercial thiamin-deficient diet,

secured from Nutritional Biochemical or the diet prepared in our lab
according to Gubler ( 1961) was used.
The rats were treated in four groups.

Each group was fed

thiamin-deficient diet ad libitum and given free access to water.
Group I, the control group, was injected subcutaneously (s. c.) daily
with 10 ug thiamin in 0. 2 ml O. 9% NaCl/100 g body wt; Group II, the
thiamin-deficient group, received daily s. c. injections of 0. 2 ml of
O. 9% NaCl/100 g body wt; Group III, the 0TH group, was injected s. c.

daily with 2000 ug of 0TH plus 10 ug thiamin in 0. 2 ml of 0. 9% NaCl/
100 g body wt; Group IV, the PTH-treated group, was injected s. c.
daily with SO ug PTH plus 10 ug thiamin in O. 2 ml of 0. 9% NaCl/ 100 g
body weight.

so
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Sacrifice Schedule
On day zero, the rats were taken off the Purina Rat Chow and
started on the thiamin-deficient diet.

Rats from the four groups were

sacrificed periodically for four to five weeks.
into two sets.

Each group was split

The rats in Set II were started on the thiamin-deficient

diet a day after Set I, but were treated the same as Set I otherwise.
This staggered treatment was employed to allow sufficient time to
process the tissues to a point where the tissues could be stored at
-20°C for extended periods.

Supplemental injections of thiamin or

antagonists were not made on the day of sacrifice.

Extraction and Neutralization
of Homogenate
The entire brain was removed from the rat immediately after
decapitation, weighed and placed in 10 ml of ice cold 0. 3M HC1O 4 per
g of wet tissue, and then homogenized for 3 min with a motorized
teflon pestle which fits snugly into a reinforced glass container immersed in an ice bath.
5900 xg at

o0 c

The homogenate was then centrifuged at

for 15 min.

The pellet was rehomogenized in 2 ml

of acid for 30 sec, centrifuged as before, and the supernatant extracts
were combined.

The tissue extracts were adjusted to pH 5-6 with 30%

KOH, centrifuged to remove KC1O
4N pH 4. 5 acetate buffer.

4

and then adjusted to pH 4-5 with

This solution will be referred to in the

following text as the neutralized tissue extract.
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Isolation of TDP and TTP
Approximately one-sixth of the neutralized tissue extract was
placed in a glass column 1/4 in. in diameter with a 3 ml reservoir
seated at the top.
CG-SO.

The column was filled 5 3 / 4 in. with Amber lite

This resin is equivalent to the Rexyn 102 used by Sharma

and Quastel {1965).

The resin was washed and prepared for use

according to their procedure.

After the aliquot had descended into

the resin, 4 ml of distilled water were added to the column which
eluted the anionic thiamin di- and tri-phosphates from the resin
while the free thiamin and TMP were retained on the column.

The

samples were then prepared for dephosphorylation.

Depho sphoryla tion
One ml of 4N, pH 4. 5 acetate buffer and 50 mg of dry Taka
Diastase were added to each sample, the tubes were covered with
parafilm and were then incubated at 48-50°C for 3 hr.

The samples

were then passed through a Decalso column as described below.

Decalso Purification
This procedure is a modification of the procedure reported
by Morita et al. (1969).
or sized before use.

The Decalso resin was not washed, rinsed

About 1. 5 g of Decalso was allowed to settle

into a glass column, 1 /4 in. inner diameter, with a 20 ml reservoir on the top.

The column was equipped with a glass stopcock.
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After the column was washed with 25 ml of 0. 5% acetic acid and ZS ml
of water, the sample was poured into the column and allowed to drain
into the resin.

About 60 ml of boiling water was then poured through

the column and the elute was discarded.

The thiamin, HET or PTH

was eluted from the column with 25 ml of hot 20% KCl in 0. 1 N HCl.
The 20% KCl eluent was drained into a 25 ml volumetric flask.

The

column material was not reused but was discarded after each run.

Preparation of Total Thiamin,
HET and PTH Samples
About one-sixth of the original neutralized tissue extract was
used for these determinations.

This aliquot was not passed through

the Amberlite CG-50 column but was prepared for dephosphorylation
as previously described.

This sample contains the free and phosphory-

lated species of thiamin, HET and PTH.

Preparation of Free Thiamin Samples
About two-thirds of the volume of neutralized tis sue extract
was used for the determination of free thiamin due to its low concentration in the tissue.

This sample was not dephosphorylated and was

placed directly onto the Decalso column for purification as previously
described.
Calculations of Thiamin,
HET and PTH Levels
Thiamin, HET and PTH were calculated as nanomoles of
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thiamin chloride hydrochloride (mol. wt. 337), HET chloride hydrochloride (mol. wt. 381) and as PTH bromide hydrobromide (mol. wt.
420) respectively per g wet tissue.
nanomoles
g wet tissue

C

The formula is defined as follows:

= AxBxo x

E

FxG x 1000

A = fluorescent reading of samples minus blank
B = ug of pure thiamin, HET or PTH used as standards
divided by the respective fluorescent reading of the
standard minus blank
C = 25, which is the volume of the sample eluted from the
Decalso column with 20% KCl in 0. lN HCl
D = aliquot of C used in the assay
E = total volume of neutralized tissue extract
F = aliquot of extract used per as say
G = appropriate molecular weight
Fluorescent Assay
The methods used to determine the levels of thiamin, HET
and PTH in the tissue homogenates are based on the specific oxidation
of each to strongly fluorescent compounds which can be selectively
monitored at certain excitation and emission wavelengths.

Approp-

riate aliquots, ranging up to 8 ml of the respective sample purified
on the Decalso column, were used so that about 0. 1 ug of thiamin or
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HET and about 0. 3 ug of PTH were fluorometrically assayed.

Pure

thiamin, HET and PTH were dissolved in 20% KCl in O. lN HCl and
appropriate aliquots of these standards were oxidized at the same
time and in the same manner as in the respective assays of tissue
samples.

Thiamin Assay.

This procedure is based on the methods

reported by Morita et al. ( 1969 ).

An appropriate aliquot of the total

thiamin sample which was purified on the Decalso column was placed
in a 50 ml glass conical tube and mixed for 5 sec on a Genie vortex
mixer with 0. 3 ml of

1% HgC1 2 . Two ml of 30% NaOH were added to

each tube to complete the oxidation of thiamin to thiochrome.
samples were mixed for 5 sec.
NaOH.
sample.

The

The blank received only 2 ml of 30%

Ten ml of distilled isobutyl alcohol were then added to each
The tubes were then mixed on a Rotary Evapo-mix shaking

unit for 2 min in such a way that the liquid climbed the walls of the
container and rotated rapidly around the tube.

This mixing technique

provided uniform and efficient extraction of the thiochrome from the
aqueous layer into the alcohol layer.

A similar extraction procedure

was performed on the oxidized HET and PTH samples.

The samples

were centrifuged at 100 x g and about 4 to 5 ml of the alcohol layer
were placed in 75 x 12 mm unmatched borosilicate or pyrex tubes.
The samples were placed in the door compartment of a Model 111
Turner Fluorometer and assayed at an excitation wavelength of 365
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nm and emission wavelength of 436 nm.

These wavelengths were

obtained using a #7-60 filter on the excitation light and a #12.A and
#47B filter on the emission light.
HET Assay.

Another 5 to 8 ml aliquot of the total thiamin

sample which was purified on the Decalso column was used for the
HET determination.

This oxidation procedure is also based on the

assay reported by Morita et al. ( 1969). Two ml of 30% NaOH were
added to the sample aliquot.

The solution was mixed for 5 sec on the

Vortex mixer, mixed again for 5 sec with two drops of 0. 01% HgC1 2
and then briefly mixed with 0. 3 ml of 1% K 3 Fe(CN)6 in water.

The

blank prepared for the thiamin sample assay served as a blank for
the HET determination also.

The sample and blank were then extracted

with 10 ml of distilled isobutyl alcohol and fluorometrically assayed on
the Turner Fluorometer exactly as de scribed previously for the
thiamin as say.

PTH Assay.

This oxidation procedure is a modification of

the procedure reported by Morita et al. ( 1968a). Two ml of 1%
K3Fe{CN)6 in 10% NaOH were added to 3 to 8 ml of the total thiamin
sample that had been purified on the Decalso column.

The solution

was mixed for about 5 sec after which the pyrichrome was extracted
into 10 ml of distilled isobutyl alcohol as previously de scribed.
Four to 5 ml of the alcohol were transferred to a cuvette
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and the fluorescence was monitored on the Farrand Spectrofluorometer using 430 nm excitation wavelength and 460 nm emission wavelength.

RESULTS
Weight Gain of Rats
The control rats gained at the rate of 6. 4 and 4. 8 g per day
in the 1970 and in the 1971 assays respectively for three weeks of
treatm.ent.

At this time the average weight of the rats ranged from

240 to 250 g (see Figures 5 and 6).
The thiamin-deficient rats gained weight at the same rate as
the controls for the first six and thirteen days respectively in the 1970
and in the 1971 analyses, after which time the thiamin-deficient rats
then gained at a subnormal rate for four days.

The rats then rapidly

lost weight at the average rate of 5 to 6 g per day until the animals
were sacrificed.

The five thiamin-deficient rats in the 1970 analysis

that were sacrificed after twenty-seven days of treatment were about
7 g below starting weight.

In the 1971 treatment period, the ten

thiamin-deficient rats sacrificed on treatment day 25 averaged 5 g
above their starting weight.

The four thiamin-deficient rats in this

group that were allowed to live for up to thirty-two days of treatment
averaged 30 g below starting weight.

The weight gain was 53 and 58

g above the starting weight in the 1970 and the 1971 analyses respectively (see Figures 5 and 6).
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The OTH-treated rats, according to the 1970 and 1971
analyses, responded in a similar fashion and did not gain more than
20 g above their starting weights during the entire treatment period
of twenty-seven and twenty-five days respectively.
The PTH-treated rats used in the 1970 and 1971 analyses,
for seven to nine days, grew at the same rate as the controls.

After

the time the peak weight of the rat was reached, the PTH-treated rats
lost on the average of 3 and 7 g per day respectively.

Thiamin and HET Assays
The major steps in the extraction of thiamin and HET from
the rat brain include homogenation and deproteination, dephosphorylation by incubation at 48°C for 3 hr and finally absorption and elution
from the Decalso column.

The overall recovery of thiamin and HET

was determined as well as the recovery at each major step of the
analysis.

It was found that 99. 6 and 98. 5% of the total thiamin and

total HET respectively was extracted from the brain tissue by the
procedure described in Methods.

The recovery of thiamin and HET

from dephosphorylated, deproteinated brain homogenate was 95 to
102% and 96. 5% respectively (see Tables 3 and 4).

When thiamin was

added to deproteinated brain homogenate and incubated at 48°C for
3 hr and subsequently purified on the Decalso column, 97% was recovered.
When HET was treated in this way, only 84% of the HET was
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TABLE 3
ELUTION OF THIAMIN FROM DECALSO COLUMN
Readings on Turner Fluorometer ~ Standard Error
Solution A
(Column-treated
homogenate +
pure thiamin)
40. 5 f 0. 7
(5 samples)

Solution B
(Column-treated
homogenate)
2.0
(2 samples)

% Recovery = 40, 5 - 2
40.5

X

Solution C
(Pure thiamin
solution - no
column treatment)
40. 5 ! o. 33
(6 samples)

100 = 95%

Solution A:

To 8 ml of dephosphorylated deproteinated brain homogenate is added O. 1 ml of thiamin solution containing
207 ug/ml.

Solution B:

The dephosphorylated brain homogenate.

Solution C:

O. 1 ml of thiamin solution containing 207 ug/ml
of 0. lM acetate buffer, pH 4. 5.

+ 8 ml

1 ml of Solutions A and R is placed on a Decalso column.
The thiamin is eluted with 25 ml of 20% KCl/0. lN HCl.
One ml of Solution C is placed in a 25 ml volumetric
and is diluted with 20% KCl/0. lN HCl to the mark. One
ml of each of the above solutions is assayed according
to the thiamin assay.
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TABLE 4
ELUTION OF TI-IlAMIN PLUS HET FROM DECALSO COLUMN
Readings on Turner
Solution A
(Column treated
homogenate +
thiamin + HET
Thiamin
HET
(6 samples)
54 +
_

o. 4

58

°t

1. 4

t

Standard Error

Solution B
(Column treated
homogenate)

Solution C
(Pure thiamin
+ HET)

Thiamin
HET
(6 samples)

Thiamin HET
(6 samples)

7.0

3.0

46°t0.4

% Recovery of thiamin = 54 - 7 x
46
% Recovery of HET = 58 - 3 x
57

57 °t 0.9

100 = 102%

100 = 96. 5%

Solution A:

Exactly O. 1 ml containing 19. 8 ug of thiamin and 0.1 ml
containing 20. 3 ug of HET is diluted to 25 ml with
dephosphorylated and deproteinated brain homogenate.

Solution B:

Dephosphorylated brain homogenate.

Solution C:

25 ml of O. lM acetate buffer, pH 4. 5, containing 19. 8
ug of thiamin and 20. 3 ug of HET.
Four ml of Solutions A and B are purified on the Decalso
column as previously described. Four ml of Solution C
is diluted with 20% KCl/0. lN HCl. One ml of each of
the 20% KCl/0. lN HCl solutions is assayed for thiamin
and for HET according to the thiamin and HET assay,
respectively.
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recovered (see Table S).

Since all the thiamin and HET was recovered

from Decalso column treatment (see Tables 3, 4, and 6), 16% of the
HET was destroyed by the 3 hr incubation at 48°c.

The average per

cent error associated with the thiarnin and HET assay using pure
thiamin and HET samples is about 1% (see Table 7).
The oxidation of thiarnin to thiochrome by 1% HgClz was
found to be specific for thiarnin in the presence of HET, as reported
by Morita et al. (1969) (see Table 8), and in the presence of excess
PTH (see Table 9).

The 1% HgC1 2 oxidation procedure does not

oxidize the PTH to pyrichrome.

The fluorescent scan--with blank

subtracted- -of the oxidation product of pure thiamin and thiamin that
was extracted from the brain of control and twenty-one day PTHtreated rats are similar (Figure 7) at high and at low concentrations
in the as say.

It was determined that the total thiamin, as well as the
TDP plus TTP levels in deproteinated, dephosphorylated rat brain
homogenate were not significantly altered by freezing at -20°C for
ten days (see Table 10).
in Methods.

The homogenate was prepared as described

TDP could be recovered completely from brain homo-

genate as the diphosphate.

That is, the diphosphate was not dephos-

phorylated by phosphatases in the homogenate and was not lost by
binding to the insoluble fraction.
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TABLE 5
RECOVERY OF THIAMIN AND HET FROM DEPROTEINATED
BRAIN HOMOGENATE AFTER INCUBATION AT
48°C FOR THREE HOURS
Readings on Fluorometer ~ Standard Error
Solution A
(Incubated columntreated homogenate
+ thiamin + HE T)
Thi am in as saya
HET assayb

Solution B
(Incubated columntreated homogenate)

Solution C
(Pure thiamin
+ HET)

Thiamin as say
HET assay

Thiamin as say i..:
HET assayd

72 : 0. 9a

0

74:l.6c

~ 1.5b

0

61: 0.5d

51

(8 samples)

(4 samples)
% Recovery of thiamin

=

72 - 0 x
74

% Recovery of HET = 51 - 0 x
61

100

=

97%

100 = 84%

Solution A:

4 ml of deproteinated brain homogenate is placed in 10
ml test tubes containing 40. 5 ug HET and 39. 6 ug
thiamin. To this solution is added 1 ml of 4N acetate
buffer, pH 4. 5.

Solution B:

4 ml of brain homogenate only.

Solution C:

40. 5 ug HET and 39. 6 ug thiamin in 4 ml of water plus
1 ml of pH 4. 5, 4M acetate buffer.
Solution C is stored at 4°C while Solutions A and B are
incubated with 50 mg of Taka Diastase at 48°C for 3 hr.
After incubation the solutions are purified on the Decalso
column. All of Solution C is placed in a 25 ml volumetric
and is diluted to the mark with 20% KCl/0. lN HCl.
Exactly 0. 1 ml of each of the 20% KCl/0. lN HCl solutions is analyzed according to the thiamin and HET assay.
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TABLE 6
ELUTION OF HET FROM DECALSO COLUMN
Readings on the Fluorometer : Standard Error
Solution A
(Column-treated
homogenate + HET)

Solution B
(Column-treated
homogenate)

33 ~ 0. 7
( 6 s ample s )

1
(4 samples)
% Recovery

=

33 - 1 x
33

100

Solution C
(Pure HET)
33 +
_ 0. 7
(6 samples)

=

97%

Solution A:

Exactly 20. 2 ug HET is placed in 8 ml of dephosphorylated and deproteinated brain homogenate.

Solution B:

Dephosphorylated brain homogenate.

Solution C:

20. 2 ug of HET is placed in 8 ml of 0. lM acetate buffer.
One ml of Solutions A and B is placed on a Decalso
column and is eluted with 25 ml of 20% KCl/0. lN HCl.
One ml of Solution C is added to a 25 ml volumetric
and is diluted to the mark with 20% KCl/0. lN HCl.
Exactly 1. 5 ml of each of the above 20% KCl/0. lN HCl
solutions is analyzed for HET according to the HET
assay.
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TABLE 7
AVERAGE PER CENT ERROR ENCOUNTERED IN THE
THIAMIN, HET AND PTH ASSAY

Thiamin As say
Mean!: Std
Error*

%

Error

HET Assay
Mean +
- Std
Error

PTH Assay

%

Mean "! Std
Error*

Error

%

Error

68

-t

0. 4

0.6

58

0. 8

1. 4

31 ~ o. 4

1. 3

70

-t o. 4

0.6

39 ~ 0. 2

0.5

40 : 0. 7

1.8

31-to.3

1.0

!

± 0. 5
74 ± 0. 4

0.7

40 : 0. 5

1. 3

0.5

41 : 0. 2

0.5

± 0. 3

0.5

47

± o. 3

0.6

64: 0. 7

0.9

47

± 0. 6

1. 3

63 : 0. 4

0.6

44

!

1. 1

61±0.3

0.5

56 ~ 0. 3

0.5

-t o. 3

o. 5

Average
% error

0.7

67

59

65

o. 4

0.9

1. 3

*Six aliquots are used to determine each mean. The mean is
the average reading on the Turner fluorometer scale of 100 units.
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TABLE 8
THI.AMIN AND HET ASSAY STUDIES

Assay
HET

Thiamin

ug Thiamin

ug HET

o.

10

0.00

o.

10

0.00

Other
Treatment

o. 01%

Number
Deter minations

Fluorometer
reading
: std.
error

5

0.0

3

1 - 4

HgClz
was
not
added

0.00

0. 10

3

43

t

0. 10

0. 10

3

43

± 0. 4

7

64

!

0. 10
0.00

0.20

5

o.

0.05

3

10

0. 4

0. 6

0.0
63

!

0. 6

TABLE 9
LACK OF INTERFERENCE OF PTH IN THE THIAMIN ASSAY

ug of thiamin added to assay

0 . 06

0.06

0.06

ug of PTH added to as say

4.96

2.48

0.00

Ratio of ug thiamin/ug PTH

1/83

1/41

1/0

100.00

100. 00

Fluorometric* reading of solutions expressed
as percent of reading of pure thiamin.
Each value represents the mean of three
determinations.

*Turner

100.00

Fluorometer was used.
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Fig. 7. - -Fluorometric scan of thiochrome formed in the
thiamin as say using ( 1) 5 ml of purified brain extract from control
rat, (2) 5 ml of purified brain extract from PTH-treated rat,
(3) 0. 12 ug of pure thiamin per assay, (4) 0. 05 ug of pure thiamin
per assay, and (5) 0. 02 ug of pure thiamin per assay. The thiochrome produced in these assays was scanned on the Farrand
Fluorometer using 360 nm excitation wavelength. The blank
reading was subtracted from each sample reading.
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TABLE 10
THIAMIN LEVELS IN FRESH AND FROZEN
BRAIN TISSUE HOMOGENATES
Fresh tissue homogenate

The same homogenate that was stored
at -20°C for 10 days

Total thiamin 6. 5 ~ 0. 05

6.7 + 0.08

TDP

+ TTP

5. 3 +
- 0. 08

5.3

+

0.06

There is no significant change in the thiamin levels in fresh and
stored homogenates.
Values are expressed as the mean of four rat brains as nanomoles
thiamin• HCl/g wet tissue ! standard error.

Thiamin does not interfere with the HET assay because it is
destroyed prior to the alkaline potassium ferricyanide oxidation step.
When thiamin and HET are rapidly mixed on a vortex mixer in a
solution containing 5 ml of 20% KCl in 0. lN HCL 2 ml of 30% NaOH
and 2 drops of 0.01% HgClz, the thiamin is completely destroyed in
a few seconds and only 6% of the HET is destroyed.

If the 0. 01% HgClz

reagent is not added to the above solution, 1 to 4% of the thiamin is
not destroyed (see Table 9).

This report is not in complete agreement

with the assay used by Morita~ al. (1969).

They incubated the above

solution for 5 min in order to destroy all the thiamin and only 20% of
the HET.

When attempting to duplicate their 5 min incubation tech-

nique, a 40% loss of HET was observed (see Figure 8) .

It should be

noted from Figure 8 that the standard deviation of the HET assay
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Fig. 8. --Rate of breakdown of HET in 2 ml of 30% NaOH
plus 0. 1 ml of 0.01% HgClz for up to 5 min of incubation. Each
point represents the mean of 4 samples
standard deviation. The
HET was oxidized to thiochrome by 0. 3 ml of 1% K 3 Fe(CN)6. The
thiochrome was then extracted in 10 ml of isobutyl alcohol. The
fluorescence was read on the Turner fluorometer, with excitation
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TABLE 11
INTERFERENCE OF PTH IN THE HET ASSAY

ug of HET added to assay

0.06

0.06

0.06

0.06

0.06

ug of PTH added to as say

4.96

1 . 24

0.62

0.37

0.06

Ratio of ug HET /ug PTH

1/83

1/20

1/10

1/6

1/1

175.00

116.00

108.00

103. 00

100.00

Fluorometric* reading of
solutions, expressed as
per cent of reading of
pure HET. Each value
represents the mean of
three determinations.

*Turner Fluorometer was used.
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increases several fold as the incubation time is extended from 5 sec
up to 5 min.
Since PTH is sensitive to alkaline K 3 Fe(CN) when the PTH
6
concentration is greater than the HET concentration in the HET assay,
a significant amount of PTH is assayed as HET.

However, until the

ratio of ug PTH/ug HET is greater than 20/1, the error in the HET
assay is less than 16% and increases to 75% when the ratio of ug of
PTH/ug of HET increases to 83/1 (see Table 11).

The fluorescent

scan of the oxidation product of pure HET and of HET extracted from
control rat brain are similar (see Figure 9) at high and low concentrations.
A sample of the HET received from Dr. Morita as a gift
could be separated from pure thiamin by paper chromatography,
using an ascending n-butanol-ethanol-water solvent system in a ratio
of 3. 1: 1. 5: 1. 5 (see Figure 10).

Morita et al. ( 1968c) reported simi-

lar results using thin layer chromatography.

The lowest level of

thiamin or HET that can be detected is about 20 nanograms /assay.
The tissue blank in all the assay·s is identical to the blank obtained
using pure 20% KCl in O. lN HCl.
Pure PTH, when mixed with deproteinated, dephosphorylated
brain homogenate, was completely recovered from the Decal so
column (see Table 12).

The average per cent error associated with

the PTH assay was 1% (see Table 7).

Thiamin and HET do not
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Fig. 9. --Fluorometric scan of thiochrome formed in the
HET assay, using (1) 0. 12 ug of pure HET per assay, (2) 5 ml of
purified extract from control rat brain, and (3) 0. 05 ug of pure
HET per assay. The thiochrome produced in these assays was
scanned on the Farrand Fluorome ter using 360 nm excitation wave length. The blank reading was subtracted from each sample
reading.
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0

Thiamin

0

HET

0

0

0

0
00

Thiamln + HET

Thiamin

HET

Fig. 10. --Chromatographic separation of thiamin and HET
using an ascending n-butanol-ethanol-HzO (3. 1: 1. 5: 1. 5) solvent
system. The Rf values of thiamin and HET are O. 51 and O. 59
respectively. Two ul of solutions containing 200 ug thiamin/ml and
100 ug of HET /ml were spotted on Whatman #1 paper.
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TABLE 12
ELUTION OF PTH FROM DECALSO COLUMN
Readings on Farrand Spectrofluorometer "±" Standard Errt:'r
Solution A
(Column-treated
homogenate +
PTH)

Solution B
(Column-treated
homogenate)

31 : o. 3
(6 samples)

Solution C
(Pure PTHNo column
treatment)

+
31.0_0.4
(6 samples)

0

% Recovery

=

31 - 0 x
31

100

=

100%

Solution A:

To 8 ml of dephosphorylated and deproteinated brain
homogenate is added 0. 1 ml containing 27 ug PTH.

Solution B:

Dephosphorylated brain homogenate.

Solution C:

27 ug of PTH in 0. 1 ml solution is added to 8 ml of
0. lM acetate buffer, pH 4. 5.
Two ml of Solutions A and B are placed rm a Decalso
column and the PTH is eluted from the column with 25
ml of 20% KCl/9. lN HCl as previously described. Two
ml of Solution C is placed in a 25 ml volumetric and is
diluted to the mark with 25 ml of 20% KCl/0. lN HCl.
Exactly 0. 5 ml of each of the above 20% KCl/0. lN HCl
solutions is assayed according to the PTH analysis.

78
interfere or contribute significantly to the PTH assay until the ratio
of ug of thiamin plus HET /ug of PTH was 6/1.

The error in the PTH

assay was only 21% when the ratio of ug of thiamin and HET /ug of
PTH was 60/1 (see Table 13).

The fluorescent spectra of PTH in the

purified brain homogenate is similar to the fluorescent spectra produced by oxidation of pure PTH samples by basic K3Fe(CN)

6 (see

Figure 11).
Total Thiamin Levels in Control,
Thiamin-Deficient, OTH- and
PTH-treated Rats
The data presented in this dissertation represents two different groups of rats which were analyzed during the summer of 1970
and again on another group of rats during the summer of 1971.
procedures described in this paper cover the 1971 analysis.

The

The

methods used for the two analyses were similar, with the exception
that in the 1970 analysis, the homogenate was not purified on the
Decalso column.
There is no significant difference between the brain total
thiamin levels of the control rats and the OTH-treated rats in the 1970
assays even with oC= 0. 1 in a two-tailed test. 4 In the 1971 assays,
there were no significant differences between the brain total thiamin
levels in the control and the OTH-treated rats.

However, there is a

4unless otherwise sta.ted the student t test for significance
is used in a two-tailed test.
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TABLE 13
INTERFERENCE OF TIDAMIN AND HET IN THE PTH ASSAY

ug of PTH added to assay

0.37

0.37

0.37

0.37

ug of thiamin added to
assay

0.36

0.72

1.8

7.2

12

ug of HET added to assay

0. 12

0.24

0.36

1. 2

12

Ratio of ug of thiamin/ug
of HET /ug of PTH

1/0. 3/1

2/0. 8/1

Fluorometric~:c reading of
solutions, expressed as
per cent of reading of
pure PTH solution. Each
value represents a mean
of three determinations.

100

100

0.37

0.37

0.37

10
10

5 /1/ 1

20/3/1

30/30/1

27/0/1

0/27 /1

106

110

121

118

119

,t,

"'Farrand Fluorometer was used.

00

0

81
significant difference between the brain total thiamin levels in the
control rats assayed in 1970 and in 1971 (see Tables 14 and 15,
Figure 12).

The reason for the difference between the two sets of

assays has not been recognized.

The rat brains assayed in the 1970

assays were extracted in a slightly different manner than used in the

1971 assay.

The rats sacrificed in the 1970 analysis were lightly

anesthetized with ether before they were decapitated and the brain
was then quickly removed and placed in a vial kept in an ice bath until
it was homogenized in O. 3M HClO .
4

This slight difference in tech-

nique was not felt to be a meaningful factor since only the rats in the
control and OTH-treated group seem to be affected.

The total thiamin

levels in the 1970 assays in the brains of the control and OTH-treated
rats were 50% higher than those observed in the 1971 assay.
The brain total thiamin levels in the thiamin-deficient rats in
the 1970 analysis were significantly lower than the brain levels in the
control rats by treatment day 2 ( oC= 0, 005) and decreased to 24% of
the control levels on treatment day 2 7.

The brain total thiamin levels

in the thiamin-deficient rats in the 1971 analysis were not significantly
different from the brain levels in the control rats until treatment day
9 ( oC > 0. 05) and steadily dec1~eased to 36% of the control levels on
treatment day 36, the terminal day,

It should be noted that in the

PTH assay, since the ratio ug of thiamin and HET /ug of PTH was
less than 4/1 during the treatn:ent period, there was no error in the
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TABLE 14
BRAIN LEVELS OF TOT AL THIAMIN, FREE THIAMIN, TMP
AND TDP + TTP IN CONTROL, THIAMIN-DEFICIENT,
OTH- AND PTH-TREATED RATS AND PTH LEVELS
IN PTH-TREATED RATS--1970 ANALYSIS
Treatment
day
Total Th
Levels

TDP +
TTP

Free Th
Levels

TMP
Levels

No.
Rats

Con

Treatment
% of
Total Th

a

± 0. 34

2
7
14
21
27

5
5
5
5
5

8.2
6.2
5.9
6. 1
5.8

± 0. 12
t 0. 23
± 0. 20

100
100
100
100
100

7
14
21
27

5
5
5
5

4.6 -t 0. 24
4.7 ± 0. 13
5. 1 -t 0. 13
4. 3 ± 0. 17

75
79
84
74

2
7
14
21
27

5
5
5
5
5

0.
0.
0.
0.

± 0. 02

6
2
2
1
1

7
14
21
27

5
5
5
5

1. 4
0. 1
0.9
1.5

o.

± 0.

50
10
10
10
10

13

± 0. 09

± 0. 09

± 0. 05
± o. 09

23
14
15
25

Deficienta
5.9
3.7
2.3
1. 6
1. 4

± O. 39b
± 0. 34b

± 0. 09b
± 0. 10b
to. 05b

3. 1 ± 0. 24b
1.8 -t 0. 18b
1. 6 ± 0. llb
1. 7 ± 0. 09b
0_33±0.02
0. 10 ± 0. 09
0. 04 ± 0. 09
0
0.6
0.5
0.0
0

PTH Levels in PTH-treated Rats (5 rats/determination)
Day of Treatment

Mean

2
7
14
19

error.

t

Standard Error
1.5
5.3
4.8
5. 1

aMeans expressed as nanomoles/g wet tissue

,

0

Significant difference at

o(

o. 17
0.44
0.54
0.36
± standard

= 0. 005 in a two-tailed t test.
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TABLE 14- -Continued

% of

OTHa

Total Th

± o. 23

100
100
100
100
100

8.8
5.8
6.7
5.8

! o. 25

83
78
98

5.2
5. 5

t 0. 18
t o. 23

5.0

i: 0. 31

6
1
2

o. 71 i: 0. 06
0. 14 ± 0. 03
o. 14 ± 0. 02

o.
16
21
25

± 0. 28

± o. 06

1

i:

o. 01

Treatment
% of
Total Th

PTHa

~ 0. 12b

100
100
100
100

l. 6
0.5
0.4

± 0. 21b
± 0. 04b
± 0. 12b

90
76
66

0. 1
0
0. 0 l

± 0. 01

100
100
100
--- day 19
100

5.8
1.8
0.7
0.7

89
82
- - day 19
87
8
2
2
-- day 19
l

0.5
l. l

9
16

0.7

12

± O. 36b

% of
Total Th

0. l
0.2
0.2

± o. 25b

~ 0. 09b

±0

3
0
6
6
24
28
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TABLE 15
BRAIN LEVELS OF TOTAL THIAMIN, TDP + TTP AND
HET IN CONTROL, THIAMIN -DEFICIENT, OT HAND PTH-TREATED RATS AND PTH LEVELS
IN PTH-TREATED RATS--1971 ANALYSIS
Treatment
No.
day
Rats
Total Th
Levels

TDP +
TTP
Levels

10
8

0

4
9
18
25
33
36

8

4
10
3
7

10
8

0

4

9

7
5

18
25
32
36

HETd
Levels

10
3
7

0
4

10

9
18
25
32
36

8
4

8

9
3

7

Treatment
Cona

Treatment
No.
Total Th day
Rats

5.6±0.17
5. 0 t 0. 09
4.2±0.13
4. 1 ± 0. 26
3.8±0.17
3.6±0.16
4. 4 ± 0. 18

100
100
100
100
100
100
100

4. 8 ± 0. 24
4. 2 ± 0. 12
3.9±0.28
2.9±0.20
3. 1
0. 14
3. 3
0. 17
3. 4 +
_ o. 11

85
85
94
72
82
92
76

18
25
32
33

o. 8 ± 0. 04
1. 2 +
- 0. 22
0. 4 t 0. 02
0. 8 +
- 0. 08
0. 8 +
- 0. 07
1.6±0.17
0. 7 t 0. 05

14.4
23.7
10. 3
20.0
19.7
43.0
16.0

4
9
18
25
32
33

±
±

Treatment

% of

10
9
9
10

4

9
18
25
32
33

3
4

10
9

4
9

8

10

4

5

10
9
8
10
3

4

Deficienta
4. 9 + o. 12
3. 2 + 0. 11c
3. 2 + 0. 16b
1. 8 -I 0. 16c
1. 3 + 0. 25c
1. 7 + 0. 21 C
4. 1 ± 0. 12
3_5±0.18
2.s±o.13
1. 5
0. 14c
1.2 ± 0.19c
1. 4 ± 0. 25c

±

1. 1 +
- 0. 09
0. 4
0. 02
+
o. 9 - 0. 11
0.5 +
- 0.09
+
0. 6 - 0. 03
0. 5 ± 0. 12

±

PTH Levels in PTH-treated Ratsa
Treatment Day
4

9
17
21

No. Rats
7
8
2

8

Mean -±: Standard Error

4. 6
5.0
5. 1
5.5

aMeans expressed as nanomoles/g wet tissue

0.27
0. 16
0.38
0.39

± standard

error.

bsignificant difference with o(= O. 05 in a two-tailed t test.
csignificant difference with o( = 0. 005 in a two-tailed t test.
dThe total thiamin determination includes the TDP
free thiamin and TMP but does not include HET.

+ TTP,
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TABLE 15 - -Continued

Trmt.
% Tot.
Th

100
100
100
100
100
100

--

84
78
86
93
79
26
12
29
26
47
30

Trmt. No.
day
Rats

Treatment
%Tot.
OTHa
Th

Trmt.
day

No.
Rats

Treatment
%Tot.
PTH
Th

4
9
18
25

10
10
7
8

4. 7 + 0. 20
4.6+0.19
3. 8 + o. 22
3.1+0.22

100
100
100
100

4
9
17
21

10
10
6
10

2. 1
1. 0
0. 4
0.3

0. 12c
0. 06C
0. 08c
O.Olc

100
100
100
100

4
9
18
25

10
7
8
8

3.6 + 0.28
4. 2 + 0. 08
3.1+0.07
3.3 + 0.21

76
92
82
89

4
9
17
21

10
8
6
10

2.o+o.22c
1. 1 + o. osc
0. 4 + 0. 03c
o,3+0.02c

95

4
9
18
25

10
10
7
8

1. 0 + 0. 08

21
10
19
19

4
9
17
21

9
10
6
9

0.
0,
0.
0.

0. 5 + 0. 03
o. 7 + 0. 10
o. 7 + o. 09

6
2
2
1

+
+
+
+

+
+
+
+

0.
0.
0.
0.

07c
01 C
12c
03c

100

27
17
62
36

86
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PTH assay due to the presence of thiamin or HET.

The brain total

thiamin levels in the PTH-treated rats decreased rapidly in both the
1970 and 1971 analyses and there was no meaningful difference between
the total thiamin levels in the two periods of analysis.

By treatment

day 2 and 4 there was a significant drop of 30% in the brain total
thiamin levels in the PTH-treated rats { o( = O. 005) as compared to
the corresponding control levels.

These levels decreased on the

average to 25% of the control levels by treatment day 10, decreasing
in the terminal PTH-treated rats to one -seventh of the control values.
TDP + TTP, TMP and Free
Thiamin Levels
The quantity represented by TDP

+ TTP

in all groups varied

in direct proportion to the brain total thiamin levels {see Tables 14
and 15 and Figure 13) remaining about 85% of the respective total
thiamin levels.

The level of TDP

+ TTP

in the OTH-treated rats as

compared to the level in the control rats within the same set was not
significantly different in the 1970 nor in the 1971 assays ( CJC = O. 005);
however, the brain levels in the same groups in the 1970 assay were
distinctly higher than in the 1971 assay ( oC= 0. 005).
TDP

+ TTP

The quantity

varied in the control and OTH-treated group around 85%

of the total thiamin levels.

The rate of depletion of TDP

+ TTP

as

observed in the thiamin-deficient rat in the 1970 assay was slightly
higher than in the 1971 assay.

There was a 30% decrease in the 1970
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assay from the control group (

o< =

0. 005) on treatment day 7, decreas -

ing to and remaining at 36% of the control values from treatment day
14 for the duration of the treatment period.

+ TTP

Although the brain TDP

levels in the terminal thiamin-deficient rats in the 1971 analy-

sis decreased to 43% of the control rat brain levels, the TDP

+ TTP

level was not significantly different from the control level until after
treatment day 18.
The TDP

+ TTP

levels in the brains of the PTH-treated rats

decreased to 30% of the corresponding control values by the first
analysis period in each set then decreased to a minimum average
value of 13% of the control values after two weeks of treatment ( see
Tables 14 and 15, Figure 13).
The per cent of free thi amin in the brain decreased much
more rapidly in the brains of thiamin-deficient and PTH-treated rats
than in the control and OTH-treated rats (Figure 14).

The free

thiamin levels in the brain of OTH-treated rats were significantly
higher than in the control rats on the second day of treatment, but
by the seventh day of treatment, and until the experiment was termin-

ated, the level of free thiamin in the brains of the controls and OTHtreated rats was not meaningfully different.

The TMP levels in the

brain of the control and OTH-treated rats did not vary in a regular
fashion.

The TMP levels decreased in the brain of the thiamin-

deficient and PTH-treated rats to very low levels.
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HET and PTH Levels
The HET levels in the brains of the control, thiamin-deficient,
and OTH-treated rats were not significantly different ( oC = 0. 05 ).

The

brain HET levels of the PTH-treated rats on treatment day 4 were 40%
lower than the control rats (see Tables 14 and 15, Figure 15) and
decreased rapidly to less than one-sixth of the control levels by the
terminal treatment period.

Note that the ug of PTH/ug of HET ratio

based on the HET assay varies up to 50/ 1, which means that the
error in the HET determination may be SO% or more.

However,

since the PTH levels after the first week of treatment are maintained
at a constant level in the brain, the decrease of the HET levels is
meaningful.

The brain level of HET in the control rats varied signi-

ficantly in a regular way around 0. 7 nanomoles /g wet tissue.

The

cause of this large variation has not been identified.
The PTH accumulates in the brain as the treatment progresses.

By treatment day 7 the brain PTH levels, as determined in the 1970
and 1971 analyses, approach maximum levels of 5. 0 nanomoles/g wet
tissue, which levels are close to the concentration of thiamin in brains
of the control rats (see Figure 16 ).
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DISCUSSION
The rate of weight gain of the four groups of rats in both the
1970 and 1971 analyses was similar to previous reports from Dr.
Gubler's laboratory [Gubler (1961), Cheney~ al. (1969), Park and
Gubler (1969), Bai et al. (1971)].
The recovery of thiamin and its derivatives and PTH from
rat brain tissue was good in spite of the numerous steps required to
process the extremely small amount of thiamin and PTH.

Many

investigators have reported excellent recoveries of thiamin and PTH

--

--

from rat tissues [see Rindi et al. (1961), DeCaro et al. (1961),
Morita et al. (1968a, b, c, 1969)].

The standard error determined

in each assay expressed as the average per cent error using standard
solutions of thiamin, HET, and PTH was 1% of the mean.

The

standard deviation for each assay determined using up to ten individual rat brains, however, is several fold higher.

The columns, tech-

niques and procedures used throughout this dissertational study were
uniform so it is felt that this high standard error reflects individual
biological differences in levels rather than technological errors inherent in the respective assays.

It is important to note that there was a rapid decrease of the
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brain total thiamin of the control rats in the first week of treatment.
This decrease was due to the drastic change in the thiamin intake.
The rats, when received, were allowed to feed on Purina Rat Chow
ad libitum for four days prior to the beginning of the treatment.
During this time, the rat tissues became saturated in thiamin.

The

chow contains 16 ug of thiamin/g, and rats consumed about 15 g of
chow per day; therefore, the rats consumed about 240 ug of thiamin
per day when fed the Purina Rat Chow.

When treatments started on

day zero, the control rats then received only 10 ug thiamin/ 100 g
body weight daily (s. c. ).

This drastic decrease in thiamin intake

caused the brain levels in the control rat to decrease 25% from the
day zero levels.

The levels of thiamin in the tissues of the control

rats established by the first week of treatment represent minimal
levels since 10 ug thiamin/ 100 g body weight is the daily minimal
thiamin intake required £or a normal weight gain [Scott and Griffith
(1957)].

Thus this initial decrease in the brain thiamin of the thiamin-

deficient, OTB- and PTB-treated rats includes this 25% decrease in
the thiamin levels from the corre spending day zero levels.
The brain total thiamin, TDP
and BET levels in the

+ TTP,

TMP, free thiamin,

OTB-treated rats were not meaningfully

different from the levels in the control rats.
effect on other organs of the rat.

OTB must exert its

The fact that the OTB-treated rat

does not gain weight during treatment cannot be correlated with the
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level of thiamin derivatives in the brain.

The blood-brain barrier

allows only a small amount of OTB to accumulate in the brain [Rindi
~

al. (1963)] so the daily thiamin plus OTB injections provide an

adequate amount of thiamin to the brain tissue.
rats served as another "control" group.

The OTB-treated

Note that the brain free

thiamin levels decrease to one -tenth their initial values in four weeks
of treatment in the control and OTB-treated rats.

The TMP level in

these two groups is somewhat erratic and does not show any particular
trend during treatment.

Total thiamin levels reported in this disser-

tational study in control rat brains was 8. 2 and 5. 6 nanomoles/g wet
tissue.

DeCaro

~

al. (1961), Rindi and Guiseppe (1961), and Morita

et al. (1968c, 1969) report brain total thiamin levels in normal rats
of 7. 7, 7. 1, 9. 1, and 9. 5 nanomoles/g wet tissue

respectively

In the thiamin-deficient rat, the rate of loss of total thiamin
from the brain is close to the rate of depletion reported by De Caro
~al. (1961), and McCandless and Schenker (1968) (see Tables 14 and
15, Figure 12 ).

The techniques used by the above authors probably

did not discriminate between HE:T and thiamin.

This may account

partly for their higher values of total thiamin in the brains of the
thiamin-deprived rats.

In the 1970 and 1971 analyses, the thiamin-

deficient rats reached a peak average weight gain on treatment day
11 and 15 respectively.

The brain total thiamin level in the rats at

these times of treatment are 2. 8 and 3. 3 nanomoles/g wet tissue
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respectively (see Figures 5, 6 and 12).

This total thiamin concentra-

tion seems to be a critical value, for the rats decrease in weight
rapidly as the total thiamin levels decrease further.

The TDP

+ TTP

levels on treatment day 11 and 15 in the 1970 and 1971 analyses respectively is 2. 3 and 2. 6 nanomoles/g wet tissue and drops to much lower
levels with further thiamin deprivation treatment.

The PTH-treated

rats reach their peak weight about the same time as the thiamindeficient group, yet the brain to tal thiamin levels in the former group
are one-third to one -fifth the levels of the latter group at this time of
treatment (see Figures 5, 6 and 12).

Perhaps the rate at which thiamin

is lost from other organs of the body in the thiamin-deficient rats and
the PTH-treated rats help determine the rate at which the treated rats
gain weight.

Another explanation might be that PTH treatment may not

deplete thiamin at the same rate from all areas of the brain.

Thiamin

has been reported to be depleted in a uniform rate in all areas of the
brain in the thiamin-deficient rat [Dreyfus (1961)].
The more rapid rate and extent of depletion of thiamin from
the brain of PTH-treated rats as compared to thiamin-deficient treated
rats causes the former group of rats to reach a terminal condition one
to two weeks sooner than in the latter group.
deficient rats showed signs of c onvulsions.

None of the thiaminIn the terminal thiamin-

deficient and PTH-treated rats, the total thiamin levels and TDP

+

TTP levels averaged 1. 5 and 0. 5 nanomoles/g wet tissue respectively.
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It is significant that there is a striking difference in the total thiamin

(and TDP

+ TTP)

levels in the brains of terminal thiamin-deficient

and PTH-treated rats when only the latter group experiences convulsions.

It would be extremely interesting to determine the brain level

of total thiamin, TDP

+ TTP,

and HET in terminal, convulsive

thiamin-deficient rats.
The reason for the depletion of thiamin in the brain of the
PTH-treated rats was not due to an insufficient level of daily thiamin
intake, as in the case of the thiamin-deficient rats, for 10 ug of thiamin is injected subcutaneously daily along with the 50 ug of PTH/ 100 g
of body weight.

The thiamin levP.ls in the heart and liver of thiamin-

deficient rats is much less than in PTH-treated rats, so there is a
much larger supply of tissue thiamin for the brain to draw upon in the
PTH-treated rats [Gurtner (1961), DeCaro et al. (1954, 1958, 1961),
unpublished work in Dr. Clark J . Gubler' s lab].
It is interesting that PTH accumulates in the brain rapidly

with treattnent and levels off at about 5. 0 nanomoles/g wet tissue in
the first week of treatment and remains at about this level for the next
two or three weeks of treatment (see Figure 16).

The daily intake of

thiamin in the PTH-treated rat tends to displace PTH from the tissues
[Morita et al. (1968b)], and hence acts to keep PTH from accumulating
in the brain to higher levels than was observed in this dissertational
study.

It has been established th at free PTH inhibits the following

reaction in vitro:
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thiamin

ATP
purified thiamin pyrophosphokinase

TDP

Johnson and Gubler (1968), Peterson (1970)
PTH also inhibits the active tran5port of thiamin into the animal cell
[Sharma and Quastel (1965), Rindi and Ventura (1967)].

The con-

version of free thiamin to the diphosphate is closely associated with
the active transport process.

The PTH

+ thiamin

injections caused,

in this dissertational study, a 50% depletion of total thiamin from the
brain by treatment day 3 (see Figure 12).

By treatment day 15, the

total thiamin levels had decreased to about one -tenth of the control
values.

The rate at which PTH accumulates in the brain equals approx-

imately the rate at which thiamin is displaced from the brain.

One can-

not tell from the data presented in this dissertational analysis how
much thiamin is entering the brain after the maximum levels of PTH
are reached in this tis sue.

Obviously since the total thiamin levels de -

crease in the brain tis sue, the rate of entry of thiamin into the cell
is much less than the rate at which the thiamin is displaced from its
active sites within the cell, dephosphorylated and excreted out of the
cell.

The free thiamin and TMP decrease to very low levels with

treatment showing that the TDP and TTP breakdown products do not
accumulate in the brain tissue.

The mechanisms which control the

rate of entry of thiamin into the cell, the rate of dephosphorylation of
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the thiamin phosphates, and the rate at which the TMP or free thiamin
leave the cell has not been defined but seems to operate up to the time
of death of the rat.

The distribution of thiamin in the brain tis sue of

all treated groups is rather constant throughout the treatment period.
The TDP

+ TTP levels remain at around 85% of the total thiamin in

all the groups.
The Ki of free PTH is 0. 2 uM toward thiamin pyrophosphokinase from rat brain [Johnson and Gubler (1968)

J

but the PTH

diphosphate ester has a Ki of 78 u.M for yeast pyruvate decarboxylase
[Wittorf and Gubler (1971)].

Therefore, the initial effect of PTH on

the brain tissue is probably due to the inhibition of the thiamin pyrophosphokinase activity.

Thiamin entering the tissue that cannot be

phosphorylated to the diphosphate ester would leave the cell.
PTH/(TDP

As the

+ TTP) ratio increased from about 4/1 on treatment day 7

to about 10/1 by treatment day 14, the PTH diphosphate [Morita~ al.
( l 968b)], and unpublished work in Dr. Clark J. Gubler' s lab

which is

probably formed in the tissue may effectively compete with TDP for
the active site on the TDP requiring enzymes, for the Ki of PTH
diphosphate is only three times the Km of TDP for yeast pyruvate
decarboxylase [ Wittorf and Gubler ( 1971)] .

As the treatment pro -

gresses, PTH may antagonize both of these thiamin requiring enzymes
in the brain tissue.
The continuously decreasing level of HET observed in the
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brains of PTH-treated rats can be coordinated with the reduced pyruvate dehydrogenase activity in the brain of PTH-treated rats [Gubler
(1961), Bennett et al. (1966)] and in mice [Holowach et al. (1968)]
(see Table 1).

No studies have been reported dealing with the preterm-

inal effect of PTH on the pyruvate dehydrogenase activity in the brain.
Nd;e also that the pyruvate dehydrogenase activity in the brain of OTHtreated rats is normal which fact correlates well with the brain HET
levels in the OTH-treated rats.

It is not known why the report by

Reinauer et al. ( 1968) of the pyruvate dehydrogenase activity in the
brain in thiamin-deficient rats does not agree with the same determination by Gubler (1961) and McCandless and Schenker (1968).

The

pyruvate dehydrogenase activity in the brain of thiamin-deficient rats
is decreased 25, 30, and 72% from the control rats according to
Gubler (1961), McCandless and Schenker (1968), and Reinauer
(1968) respectively.

~

al.

The first two reports tend to support the some-

what decreased levels of HET observed in this dissertational study in
the thiamin-deficient rat brains .

The 24% decrease of brain HET in

the terminal thiamin-deficient rats from the control group is not
significant in a two-tailed t test at the 95% level of confidence.

If one

felt that since HET decreases in the PTH-treated rat as the thiamin
level decreased, an increase in the HET level of the thiamin-deficient
rat is not likely, a one-tailed test is justified.

Even under these condi-

tions, a 24% decrease in the terminal thiamin-deficient group is not
significant at the 95% level of confidence.
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Another interpretation of a lowering of the HET levels would
be that HET is used up via the citric acid cycle at a faster rate as
compared to the control rat.

The AcCoA could be converted to choles-

terol and/or fatty acids at an increased rate.

The decrease in the

HET levels might be due to a rapid breakdown of the HET molecule
with no concurrent formation of AcCoA.

The first hypothesis does

not seem likely in the PTH-treated rats since the oC -ketoglutarate
dehydrogenase activity decreases in the brain of the PTH-treated
rats during treatment.

The decrease in the transketolase activity of

the brain of thiamin-deficient rats [McCandless and Schenker ( 1968),
and Brin (1962)] would not favor increased synthesis of fatty acids or
cholesterol since both processes require NADPH.

Breakdown of the

HET moiety with no concurrent AcCoA formation would be a wasteful
process and is, therefore, an unlikely route.

\

SUMMARY
The minimal level of thiamin in the rat brain that is necessary
for an adequate level of metabolism has not been reported in the literature.

However, the brain level of total thiamin, TDP

+ TTP,

and

HET in rats receiving a minimal yet sufficient daily amount of thiamin
that is required for a normal weight gain seems to be about 3. 8, 3. 3,
and 0. 7 nanomoles/g wet tissue respectively.
The TDP

+ TTP

levels in the brain of the thiamin-deficient

rat are at least twice as high as is observed in the brains of the PTH
treated rats during the entire treatment period.
of treatment the TDP

+ TTP

After fourteen days

levels are from three to five times higher

in the thiamin-deficient than in the PTH-treated rat brains.

The

minimal levels of TDP + TTP in the thiamin-deficient and in the PTHtreated rat brains were initially observed at three weeks and two weeks
respectively, although the terminal levels in the thiamin-deficient rat
brains are three times as high as the PTH-treated rats.

The minimal

level of TDP + TTP observed in the brains of the thiamin-deficient and
PTH-treated rats was 36 to 43% and 10 to 15% respectively of the
levels in the brain of the control rats.
0TH treatment does not alter the amount or distribution of
103
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the thiamin derivatives in the brain of rats treated up to twenty-seven
days so 0TH probably exerts its effects on organs outside the central
nervous system.
This report is the first comprehensive study of the effect of
thiamin-deficiency, 0TH and PTH treatment on the level of HET in
mammalian tissues.

Normal levels of HET were observed in the

brain of the OTH-treated rats for the duration of treatment.

The

brain levels in the thiamin-deficient treated rats were not significantly
different (

o(

> 0. 05) from the control group even though the HET

levels decreased 24% from the control group during the last two
weeks of treatment.

The brain HET levels in the PTH-treated rats

decreased markedly and significantly ( oC = 0. 005) below the control
group by treatment day 4, decreasing to around one -sixth the level
of HET in the controls by the third week of treatment.

The decrease

in the level of HET in brains of PTH-treated rats was assumed to
mean that the conversion rate of pyruvate to AcCoA was depressed
significantly.
The PTH levels increased rapidly in the brain to normal
thiamin levels by the end of the first week of treatment.
(TDP

+ TTP) ratio was

The PTH/

high enough by treatment day 10 so that the

PTH diphosphate could compete with TDP for the active site on the
pyruvate dehydrogenase enzyme.
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THE DETERMINATION OF THIAMIN AND ITS DERIVATIVES
IN BRAIN TISSUE OF CONTROL, THIAMIN-DEFICIENT,
OXYTHIAMIN- AND PYRITHIAMIN-TREATED RATS
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Ph.D. Degree, April 1973

ABSTRACT
The determination of total thiamin, free thiamin, thiamin
di phosphate (TDP) plus thiamin triphosphate (TTP), and total oC hydroxyethylthiamin (HET) levels in rat brain in control, deficient,
oxythiamin- (0TH) and pyrithiamin- (PTH) treated rats was accomplished. It was found that the TDP + TTP / thiamin ratio observed in
the thiamin-deficient, OTH- and PTH-treated rats . was constant and
did not differ from the ratio observed in the control rat brains. The
brain levels of TDP + TTP decreased to 39% and 12% of the control
thiamin levels in deficient and PTH-treated rats respectively. The
brain HET and TDP + TTP levels of the OTH-treated rats were not
significantly different from the controls. The HET levels in the PTH
rats decreased significantly ( oC = 0. 005) by treatment day 4 and de creased to one-seventh of the control values in the terminal stages.
A significant drop in the HET levels from the control levels was interpreted to mean that the pyruvate utilization was significantly impaired
in the brain.

